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Background: Depression is associated with a broad range of cognitive symptoms, including 
reduced attention, verbal learning and memory, executive functioning (EF), and processing speed 
(PS). Computerized cognitive training (CCT) has been shown to ameliorate the cognitive 
symptoms of depression. Younger adults, in particular, are understood to benefit more from CCT 
than older adults due to their greater capacity for neuroplasticity. However, several issues remain 
unclear about the effectiveness of CCT: (1) whether the benefits of CCT are driven by the 
specific content or by non-specific factors, such as engagement, motivation, novelty, and 
expectancy, which have been inadequately controlled in prior studies; (2) whether the benefits of 
CCT extend past the domains directly trained (i.e., far transfer); and (3) whether CCT response is 
impacted by socio-demographic and clinical variables.  To address these issues, we devised an 8-
week, double-blind randomized trial that compared the cognitive effects of PS and EF-based 
CCT (treatment group) versus verbal-based CCT (active control) in young adults with elevated 
depressive symptoms. We hypothesize PS/EF-based CCT will result in differentially larger 
improvements in near (PS and EF) and far transfer (attention and verbal learning and memory) 
than in the active control group. We also hypothesize that race, concurrent treatment and 
depression severity predicts CCT response.  
 
Methods: Forty six young adults (18-29 years old) with at least mild depressive symptoms 
(Hamilton Depression Rating Scale ≥ 10) were randomized to one of two CCT programs. 
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Participants completed a baseline neuropsychological evaluation, downloaded an app with their 
respective training program, and were instructed to train for a minimum of 15 minutes a day, 5 
days a week, for 8 weeks. Both groups had an equal and limited amount of time with research 
personal, thereby controlling for social engagement. All modules scaled in difficulty and 
provided motivational reinforcement upon performance, thereby controlling for motivation, 
novelty, and expectancy. After 8 weeks, participants returned for a neuropsychological re-
evaluation. The primary outcome variables were change scores (from baseline to week 8) of each 
cognitive test administered, as well as for mood and daily functioning. Race, concurrent 
treatment, and depressive severity were explored as potential predictors of CCT response.  
 
Results: The PS/EF group demonstrated significantly greater gains on select measures of PS and 
EF than the active control group. Comparable improvement was observed between groups on 
farther measures of cognition, as well as in mood and daily functioning. Both groups reported 
comparable levels of engagement. Differential response to CCT was noted between Whites and 
Asians, whereas concurrent treatment and depressive severity were largely unremarkable, yet 
with a few exceptions.  
 
Conclusion: PS/EF-based CCT was more effective on tasks of near transfer, but comparably 
effective as the active control on measures of far transfer. This suggests the mechanism of action 
in CCT is likely not driven by the specific training content, but on the factors common to both 
training conditions. The role of non-specific factors cannot be ruled out, given comparable levels 
of engagement and exposure to a novel and challenging activity. The possibility that CCT is 
effective insofar as it upregulates brain derived neurotrophic factor is discussed. Future research 
is recommended to better elucidate the relationships among CCT, cognitive functioning, and  
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Major depressive disorder (MDD) is the most common mental disorder in the United 
States (World Health Organization, 2017) with a past-year prevalence of 5-10% and a lifetime 
prevalence of 13-16% (Hasin, Goodwin, Stinson, & Grant, 2005; Kessler & Bromet, 2013).  
Young adults, defined as individuals between 18-29 years old, are most at risk. According to 
epidemiological studies, the past-month prevalence of depression for young adults is 6.39% and 
the lifetime prevalence is 12.02% (Hasin et al., 2005). MDD is associated with significant social, 
occupational, and health consequences, including lower educational achievement (Breslau, Lane, 
Sampson, & Kessler, 2008), chronic physical disorders (Bautovich, Katz, Smith, Loo, & Harvey, 
2014; Hayley et al., 2015; Poongothai et al., 2017), unsafe sexual activities (Morrill, Kasten, 
Urato, & Larson, 2001), unemployment and absenteeism from work (Lerner & Henke, 2008; 
Tsuchiya et al., 2012; Wahlbeck & McDaid, 2012), and suicide (Bruffaerts, Kessler, 
Demyttenaere, Bonnewyn, & Nock, 2015). Its economic burden is correspondingly large. Recent 
estimates put the current cost of MDD due to lost productivity and increased health care 
expenditures at approximately $100 billion per year in the U.S. (Greenberg, Fournier, Sisitsky, 
Pike, & Kessler, 2015). In short, MDD is a chronic, disabling, and serious public health issue.  
MDD is associated with several cognitive symptoms, including reduced attention, verbal 
learning and memory, executive functioning (EF), and processing speed (PS) (Ahern & 
Semkovska, 2017; Paelecke-Habermann, Pohl, & Leplow, 2005; Rock, Roiser, Riedel, & 
Blackwell, 2014). Impaired emotional processing and social cognition have also been 
documented (Bhagwagar & Cowen, 2008; Groenewold et al., 2015; Ladegaard, Larsen, 
Videbech, & Lysaker, 2014). There is overwhelming support for targeting the cognitive 
symptoms directly in MDD. First, cognitive symptoms commonly predate or co-occur with the 
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onset of affective symptoms (Lee, Hermens, Porter, & Redoblado-Hodge, 2012), providing a 
window of opportunity for early detection and intervention. Second, cognitive deficits have been 
shown to persist even with resolution of affective symptoms (Herrera-Guzmán et al., 2010), 
increasing the risk of relapse and recurrence (Fossati, Ergis, & Allilaire, 2002) and interfering 
with full recovery from MDD (Bortolato et al., 2016). Indeed, the presence and severity of 
cognitive deficits is the most reliable predictor of functional outcome in MDD (Majer et al., 
2004; Woo, Rosenblat, Kakar, Bahk, & McIntyre, 2016). Last, targeting the cognitive features 
would enable individuals to better benefit from interventions that target affective symptoms. For 
example, cognitive inflexibility is a predictor of anti-depressant treatment response and reduces 
the effectiveness of cognitive restructuring in psychotherapy (Lee et al., 2012).   
Computerized cognitive training (CCT) is receiving attention as a treatment for the 
cognitive symptoms of depression. CCT has been found to induce neuroplasticity in the 
cognitive control network (CCN), a brain network that is responsible for emotional processing 
and higher-order cognitive functioning.  Dysfunctional in depression, the CCN comprises the 
dorsolateral prefrontal cortex, dorsal anterior cingulate cortex, dorsal parietal cortex, and the 
precentral gyrus (Breukelaar et al., 2017). It has been proposed that CCT leads to improvements 
in the CCN and the cognitive functions this network subserves (Porter, Bowie, Jordan, & Malhi, 
2013; Preiss, Shatil, Cermakova, Cimermannova, & Flesher, 2013).  
The purpose of the forthcoming Introduction is as follows: (1) to characterize the 
cognitive deficits associated with depression as well as those preserved or less impacted; (2) to 
review the structural, functional, and neurochemical mechanisms underlying the cognitive 
deficits in depression; (3) to evaluate the extant literature on the efficacy and mechanisms of 
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action of CCT; and lastly, (4) to discuss the current limitations in the literature and potential 
directions for future research. 
 
Cognition in Depression  
Core diagnostic symptoms of depression 
 To meet DSM-5 criteria for MDD, an individual must experience overwhelming sadness 
or anhedonia for at least two weeks and it must be a significant change from his/her previous 
mood. These core symptoms must be accompanied by a minimum of five of the following 
symptoms: significant change in weight, insomnia or hypersomnia, psychomotor agitation or 
retardation, feelings of worthlessness or inappropriate guilt, diminished ability to concentration 
or to make decisions, and recurrent thoughts of death (American Psychiatric Association, 2013). 
Diminished concentration and decision-making, the core cognitive features of depression, are 
experienced by an overwhelming number of individuals with depression (Trivedi & Greer, 
2014). In an item-level analysis of depressive symptoms, Conradi, Ormel, & De Jonge (2011) 
found that the cognitive symptoms (concentration and indecisiveness) were present 85-94% of 
the time during a depressive episode and 39-44% of the time while in remission. This suggests 
that cognitive dysfunction is a hallmark feature of MDD that persists into remission. 
Additionally, while psychomotor retardation is traditionally conceptualized as an affective 
symptom, it could also fall within the cognitive domain of PS (Shura et al., 2017). Indeed, there 
are several cognitive manifestations of psychomotor retardation, such as delayed response time, 
prolonged pauses in speech, and delayed initiation of motor movements (DeLuca & Kalmar, 
2013). Qualitatively, when patients describe their difficulties with concentration and decision-
making, PS appears to be at the root of their difficulties. For example, Gonda et al. (2015) found 
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that among individuals with MDD who experience cognitive symptoms, a large proportion 
reported: “My brain feels blocked,” “the smallest task takes a long time,” and “[I] feel slowed 
down and feel my brain isn’t working.”  
 
Associated Cognitive Features of Depression   
 Attention. Most theoretical models conceptualize attention as “a complex system of 
interacting components that allows an individual to filter relevant and irrelevant information in 
the context of internal drives and intentions, hold and manipulate mental representations, and 
monitor/modulate responses to stimuli” (Strauss, Sherman, Spreen, & Spreen, 2006).  
 Both circumscribed and global deficits in attention have been documented in MDD. Most 
consistently are deficits in sustained and selective attention (Darcet, Gardier, Gaillard, David, & 
Guilloux, 2016; Eizenman et al., 2003; Paelecke-Habermann et al., 2005), which are equivocally 
attributable to deficits in underlying attentional processes of alerting and orienting (Kertzman et 
al., 2010; Lyche, Jonassen, Stiles, Ulleberg, & Landrø, 2010; Snyder, Miyake, & Hankin, 2015). 
These deficits emerge early in the disease and persist well into remission, even after correcting 
for residual mood symptoms (Weiland-Fiedler et al., 2004), and are generally independent of 
symptom severity, treatment status, and treatment utilization (Paelecke-Habermann et al., 2005; 
Rock et al., 2014). Attention deficits have been found among individuals with moderate to severe 
depression as well as with subthreshold depression (Hasselbalch, Knorr, Hasselbalch, Gade, & 
Kessing, 2012). Herrera-Guzmán et al. (2010) found that a 24-week trial of selective serotonin 
reuptake inhibitor (SSRI) or dual SSRI and serotonin-norepinephrine reuptake inhibitor (SNRI) 
treatment did not restore the sustained attentional deficits in patients with MDD, which 
corroborates with meta-analytic findings from Rock et al. (2014). The stability of attention 
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deficits is suggestive that it is a trait marker of depression (Douglas & Porter, 2009; Porter, 
Bourke, & Gallagher, 2007).  
 Learning and Memory. Learning and memory impairments appear early in the illness 
course and increase with each depressive episode (Ahern & Semkovska, 2017; Gorwood, 
Corruble, Falissard, & Goodwin, 2008). In a large sample of 8,229 patients with MDD, Gorwood 
et al. (2008) found that delayed verbal memory decreased by 2-3% with each episode, potentially 
reflecting concomitant decrements in hippocampal volume reported elsewhere (Cobb et al., 
2013; Sheline, Sanghavi, Mintun, & Gado, 1999). The deficits are more likely related to a deficit 
in acquisition than in retention or retrieval, marked by poor organizational strategies during 
encoding (Basso & Bornstein, 1999; Behnken et al., 2010); however, whether or not the deficits 
in attention and EF underlie the learning and memory deficits in MDD have been debated (Nebes 
et al., 2000).  
 EF. EF refers to a collection of complex, higher-order cognitive functions that control 
and integrate lower-level processes. It comprises several highly-interconnected, yet dissociable, 
cognitive parts, including inhibition, working memory, strategic processing, set-shifting, verbal 
fluency, and emotion regulation. EF is responsible for purposeful, goal-directed behavior and for 
facilitating adaption to novel situations (Lezak, Howieson, Bigler, & Tranel, 2012).  
 Many propose a global executive deficit in MDD (Bredemeier, Warren, Berenbaum, 
Miller, & Heller, 2016; Snyder, 2013), yet the preponderance of evidence points to 
circumscribed deficits in verbal fluency, inhibitory control, and cognitive flexibility (Baune, 
Fuhr, Air, & Hering, 2014; Biringer et al., 2005; Fossati et al., 2002; Klumpp & Deldin, 2010; 
Schmid & Hammar, 2013; Trivedi & Greer, 2014). Deficits in working memory (Baune et al., 
2014; DeBattista, 2005) and planning/organization (Trivedi & Greer, 2014) have also been 
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reported, but less consistently. In a longitudinal study by Papmeyer et al. (2015), cognitive 
inflexibility increased the risk of developing MDD among individuals with high familial risk for 
mood disorders. Other studies have found that executive dysfunction was present in remission 
and in recovery, notably in verbal fluency and inhibition (Ahern & Semkovska, 2017; 
Talarowska, Zajączkowska, & Gałecki, 2015).  Put together, executive dysfunction predisposes 
and predates the onset of affective symptoms and persists into remission, thereby reflecting a 
trait marker of depression.  
 The mechanism underlying the executive dysfunction in MDD is debatable; that is, are 
the deficits primary or attributable to another non-executive process? Proponents of the former 
purport that affective symptoms, notably rumination and negative mood, directly affects EF 
(Joormann & Tanovic, 2015; LeMoult, Yoon, & Joormann, 2016). It has been argued that 
rumination absorbs already scarce cognitive resources that could otherwise be employed for 
complex processing (Berman et al., 2011; Gotlib & Joormann, 2010; Joormann & Tanovic, 
2015). However, while compelling, this argument is limited. First, as previously mentioned, 
several studies have shown that cognitive dysfunction persists with the resolution of affective 
symptoms. A six-year longitudinal study by Sarapas, Shankman, Harrow, & Goldberg (2012) 
found that cognitive dysfunction persisted even when current and past severity were controlled, 
thereby demonstrating that it cannot simply be a consequence of low mood or decreased 
motivation consequential to low mood (Schmid & Hammar, 2013). Further, it can be reasoned 
that rumination is a consequence of poor inhibitory control (De Lissnyder, Koster, Derakshan, & 
De Raedt, 2010), wherein an individual cannot inhibit their continuous focus and rethinking of 
an event. Accordingly, some argue that the EF deficits in MDD are subserved by another process 
altogether. Receiving the most attention is the mediating role of PS.  
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 PS. PS is the maximum rate at which different cognitive operations can be performed and 
executed. This “refers to either the time required to execute a cognitive task or the amount of 
work that can be completed within a finite period of time” (DeLuca & Kalmar, 2013). PS is a 
lower-level cognitive function, or “fundamental cognitive resource,” that facilitates the 
operations of higher-level functions (Kail & Salthouse, 1994). As described in Salthouse’s model 
on PS, PS – like any resource – is limited in time, capacity, and energy. If processing is too slow, 
information that was processed earlier may be lost (a phenomenon known as the “time-limited 
mechanism”) and no longer available for integration (known as the “simultaneity mechanism”) 
(Salthouse, 1996). Therefore, the model posits that deficits in PS invariably affects efficient 
cognitive functioning and particularly EF.  
 This Processing Speed Efficiency model is substantiated by findings in the literature. 
Primary support comes from the fact that improvements in EF co-occur with improvements in PS 
(Ahern & Semkovska, 2017).  Using ROC curve modeling, Gu et al. (2016) found that deficient 
PS and EF could identify MDD from controls 82% of the time and that PS was the most 
predictive of general cognitive impairments. In a meta-analysis of young adults with MDD, 
Douglas and Porter (2009) found that poor psychomotor speed was responsible for the persistent  
deficits in verbal fluency. Additionally, Kertzman et al. (2010) found that poor Stroop 
performance was due to poor psychomotor speed, and not poor selective attention, in a sample of 
outpatients with MDD. This suggests that PS is an effective target for treating the broad 
executive dysfunction in MDD. 
 
Cognitive Abilities Preserved in Depression 
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 Most aspects of language functioning are preserved in MDD, including verbal 
comprehension, word reading, and semantic knowledge (Lamberty & Bieliauskas, 1993). 
Replication studies show individuals with MDD perform as well as healthy controls on the 
Verbal Comprehension Index (VIQ) of the Wechsler Intelligence Scale, yet worse on the 
Perceptual Reasoning Index (Gorlyn et al., 2006; Iverson, Turner, & Green, 1999). Other studies 
demonstrate VIQ performance is unaffected by depression severity, depression type, medication 
use, or patient status. Individual who attempt suicide performed comparably on the VIQ as non-
attempters, as did inpatients with melancholic versus inpatients with non-melancholic depression 
(Gorlyn et al., 2006). Verbal comprehension is so resistant to change that it can withstand most 
head traumas and acquired brain injuries, thereby serving as the basis of most measures of 
premorbid functioning (Belanger, Kretzmer, Yoash-Gantz, Pickett, & Tupler, 2009; Green et al., 
2008), because they are overlearned and well-established crystalized knowledge (Sohlberg & 
Mateer, 2017). 
 
Pathophysiology of MDD 
 Several neuroanatomical, functional, and biochemical explanations are shown to be 
implicated in the cognitive deficits of depression.  
 
Structural changes in local brain regions  
From a localist perspective, the dorsal-lateral prefrontal cortex (dlPFC), anterior cingulate 
cortex (ACC) of the ventral-medial prefrontal cortex, and hippocampus are subject to volumetric 
reductions in MDD (Amico et al., 2011; Ducharme et al., 2013; Lener & Iosifescu, 2015). The 
hippocampus can shrink an upwards of 19% bilaterally in depression, with greater loss on the left 
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than the right side of the brain (Bremner et al., 2000), corresponding to greater verbal versus 
visual memory impairments (Turner, Furey, Drevets, Zarate Jr, & Nugent, 2012). Volumetric 
reductions in these structures are most pronounced in recurrent and refractory MDD (McKinnon, 
Yucel, Nazarov, & MacQueen, 2009), yet they have also been identified in subthreshold MDD, 
(Hayakawa et al., 2013; Li et al., 2017), treatment-naïve MDD (Zhang et al., 2011), and among 
individuals at genetic risk for MDD (i.e., carrying the short allele for serotonin transporter) 
(Pezawas et al., 2005). In line, age-matched samples suggest disease severity and burden better 
account for volume loss than age (MacQueen et al., 2003; McKinnon et al., 2009), with greater 
declines associated with days left untreated (Sheline, Gado, & Kraemer, 2003), symptom 
severity (McKinnon et al., 2009), physical or medical co-morbidities (Lai, 2014; Sheline, 2000), 
and number of depressive episodes (Treadway & Pizzagalli, 2014). Morphological changes in 
MDD correspond with cognitive changes; recent advances suggest the hippocampus, while 
historically viewed as subserving long-term, declarative, and episodic memory, is also implicated 
in PS and EF (Addis & Schacter, 2012; Palombo, Keane, & Verfaellie, 2015; Rubin, Watson, 
Duff, & Cohen, 2014). In line, hippocampal volume has been shown to predict slower reaction 
time and reduced generativity of novel responses (Papp et al., 2014).   
 
Changes in functional circuitry  
With advances in neuroimaging, localist perspectives of MDD are being replaced with 
functional circuitry.  Receiving the most attention is the cognitive control network (CNN) and 
default mode network (DMN), two anti-correlary brain networks that are dysfunctional in MDD 
and which result in cognitive disturbance (Rayner, Jackson, & Wilson, 2016).  
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The CCN comprises the dorsolateral prefrontal cortex, dorsal anterior cingulate cortex, 
dorsal parietal cortex, and precentral gyrus, as well as auxiliary regions in the mesial temporal 
lobe and intraparietal sulcus (Breukelaar et al., 2017). The CCN is an externally-oriented system 
that supports higher-order cognitive functions; it is activated when we are engaged in a 
purposeful goal-oriented task. As a function of its anti-correlary relationship, when the CCN is 
activated, the DMN is off-line (Niendam et al., 2012; Rayner et al., 2016). In MDD, however, 
the CCN is hypoactive, which results in difficulties with attention, inhibitory control, novel 
generativity, planning, and working memory (Zhang et al., 2016). Accordingly, these difficulties 
map onto the clinical features of depression, such as poor concentration, indecisiveness, and 
concrete reasoning (Rayner et al., 2016).  
The DMN comprises the anterior medial prefrontal cortex, posterior cingulate cortex, and 
the angular gyrus (Greicius, Krasnow, Reiss, & Menon, 2003). It is an internally-oriented system 
that is responsible for mind-wandering, daydreaming, and internal self-talk. Ordinarily, the DMN 
is activated when the brain is “at rest” or when not engaged in an effortful task (Andrews-Hanna, 
Reidler, Sepulcre, Poulin, & Buckner, 2010; Buckner, Andrews‐Hanna, & Schacter, 2008). In 
MDD, however, the DMN is overactive and hyperconnected (i.e., greater DMN activation and 
connectivity at rest and greater deactivation when engaged in an externally-oriented task) 
(Kaiser, Andrews-Hanna, Wager, & Pizzagalli, 2015; Rayner et al., 2016); this results in 
increased rumination, critical self-talk, a negative attributional style, brooding, and suicidal 
ideation (Hamilton, Farmer, Fogelman, & Gotlib, 2015; Hamilton et al., 2011; Whitfield-
Gabrieli & Ford, 2012).  
Put together, the pathological imbalance of these anti-correlated networks characterizes 
the “neurocognitive model of depression,” wherein the DMN is hyperactive and the CCN is 
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hypoactive. This results in a hyperfocus on internal states (e.g., rumination, self-referential 
thinking) and an excessive disengagement with the outside world (e.g., amotivation and 
anhedonia) (Kaiser et al., 2015; Rayner et al., 2016).  Neuropsychological functions, such as 
working memory and response inhibition, have been shown to be compromised (Sheline, Price, 
Yan, & Mintun, 2010).   
 
Biochemical Changes in MDD 
The neutrophic hypothesis posits that depression is both caused by and treated with 
modulations in brain-derived neutrophic factor (BDNF) (Pehrson et al., 2015; Yoshida et al., 
2012). BDNF is a type of neurtrophin (a group of proteins) that is critically important in 
neuroplasticity, which refers to the brain’s ability to change in response to learning and 
experience on a neuronal level (Kolb, Muhammad, & Gibb, 2011). Concentrations of BDNF are 
markedly low in depression, associated with increased vulnerability (Molendijk et al., 2014), 
structural atrophy and functional dysconnectivity (Banasr, Dwyer, & Duman, 2011; Reinhart et 
al., 2015), cognitive and affective dysfunction (Castrén & Rantamäki, 2010; Leckie et al., 2014; 
Noble, Billington, Kotz, & Wang, 2011), and reduced neurogenesis (Jiang et al., 2017; Wei, 
Liao, Qi, Meng, & Pan, 2015). The prefrontal cortex and hippocampus are particularly subject to 
decreased spine and dendrite complexity (Boulle et al., 2016; Chen, Ernst, & Turecki, 2011). 
Clinical improvement, conversely, is associated with an upregulation of BDNF, afforded by 
antidepressants. Accordingly, there has been tremendous interest in identifying non-
pharmacological analogs that upregulate BDNF for the purpose of inducing neuroplasticity and 
improving the cognitive symptoms of MDD.  
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Cognitive Remediation for MDD  
Cognitive remediation (CR), or cognitive rehabilitation, is a non-pharmacological, 
behavioral treatment designed to improve cognition in people who have experienced a decline in 
neuropsychological functioning (Sohlberg & Mateer, 2017). This includes individuals with early 
learning disabilities, traumatic brain injury, stroke, and mental illness. A wide range of 
interventions are used to either restore or compensate for cognitive decline; yet, regardless of the 
intervention used, the goal of CR is transfer or transfer of practice, which refers to the ability to 
learn skills or knowledge in one context and apply it to another (Woodworth & Thorndike, 
1901). That is, can learned material be generalized and not simply be “taught to the test?”  
Transfer exists along a continuum, with near transfer and far transfer on opposite ends. 
Near transfer refers to the application of skills/knowledge to a context very similar, but not 
identical, to the context from which it was learned (Sandberg, 2014). For example, PS training 
(PST) leads to improvements in PS. Far transfer refers to the application of skills/knowledge to 
a seemingly unrelated context or applying skills/knowledge that are not explicitly taught/trained 
(Sandberg, 2014). For example, PST leads to improvements in EF and mood. The desired 
outcome is far transfer, yet some contend only near transfer is possible (Melby-Lervåg & Hulme, 
2013; Minear et al., 2016; Taatgen, 2013). Indeed, according to the “identical elements” model 
by (Woodworth & Thorndike, 1901), transfer of training can only occur if the transfer task 
shares similar elements or components to the practiced task.  
 
Types of Cognitive Remediation  
CR can be divided into two categories: strategy-based treatment and process-based 
treatment. Strategy based-treatments focus on teaching compensatory strategies for cognitive 
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decline, such as mnemonics, visualization, and organizational techniques. In contrast, process-
based treatments focus on targeting, training, and strengthening specific cognitive processes with 
the use of structured drills and repeated practice (Sandberg, 2014). Accordingly, the term 
“process-based treatments” is used interchangeably with cognitive training or, if the exercises 
are computerized, computerized cognitive training (CCT), and are the basis of most mainstream 
brain games software (Simons et al., 2016).  
 
Computerized Cognitive Training  
Theoretical Framework of Computerized Cognitive Training 
 CCT is situated within several theoretical frameworks, including the physical-energetic 
model (Salthouse, 2006), environmental enrichment hypothesis (Hertzog, Kramer, Wilson, & 
Lindenberger, 2008), and cognitive reserve (Barulli & Stern, 2013; Stern, 2009). Unifying these 
models is the importance of the environment to strengthen, restore, and/or preserve cognitive 
functioning  
Physical-energetic model. The physical-energetic model, more popularly known as the 
“brain as a muscle” analogy, posits that repeatedly exercising a cognitive function strengthens, 
improves, or decelerates the decline of that process – in the same fashion that physical exercise 
strengthens muscles (Salthouse, 2006). Understood in the analogy is that (1) the more a process 
is exercised, the stronger it becomes and (2) exercising one process will generalize to other 
functions. To illustrate, exercising your upper body will enable you to benchpress heavier weight 
as well as improve your swimming technique and potentially improve your cardiovascular 
health. The use of structured drills and repeated practice in CCT accords with this model. Of 
note, the model has been criticized for placing a greater emphasis on quantity than quality and 
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for discounting the role of human factors, such as fatigue (Boot & Kramer, 2014; Melby-Lervåg 
& Hulme, 2013; Redick, Unsworth, Kane, & Hambrick, 2017). 
Environment Enrichment Hypothesis. The environment enrichment hypothesis was 
originally born from animal models and then extended to humans. It is the idea that “greater 
complexity of environment (i.e., diverse stimuli), greater demands for complex decision making, 
and social and physical stimulation enhances cognitive development” (Voss, Vivar, Kramer, & 
van Praag, 2013).” An enriched environment is one that affords opportunities for learning and 
cognitive stimulation, physical activity, and/or social interaction, as to induce neuroplasticity and 
a sequlae of structural and functional changes (Garthe, Roeder, & Kempermann, 2016; Herholz 
& Zatorre, 2012; Hertzog et al., 2008; Kempermann, Song, & Gage, 2015; Voss et al., 2013).  
 Corresponding to these changes are improvements in cognitive and affective functioning. 
Environment enrichment results in increased learning, memory, PS, and several aspects of EF 
(Diamond, 2015; Donnelly et al., 2016; Mahncke et al., 2006; Rebok et al., 2014). Affectively, 
antidepressant and anxiolytic effects have been reported (Cooney, Dwan, & Mead, 2014; Rebar 
et al., 2015; Schuch et al., 2016).  
 Of importance is that enrichments effects are temporary, lasting a maximum of six 
months (Kempermann & Gage, 1999). This speaks to the role of novelty in stimulating brain 
changes and corresponding changes in cognition and affect.  To induce and maintain enrichment 
effects, many CCT platforms scale in difficulty or provide an assortment of games. Therefore, it 
has been argued that the benefits of CCT are more a consequence of novelty than due to CCT, 
per se (Boot, Simons, Stothart, & Stutts, 2013; Motter, Devanand, Doraiswamy, & Sneed, 
2016b); (see Novelty section).  
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Cognitive reserve. Related to environment enrichment is the concept of cognitive 
reserve, which states that lifetime exposure to intellectual or cognitive activities protects against 
brain damage or injury (Stern, 2002). Cognitive reserve is estimated by an individual’s highest 
educational attainment, occupation, participation in learning-based leisure activities (e.g., 
learning a second language), and intelligence quotient (IQ) (Kesler, Adams, Blasey, & Bigler, 
2003). Individuals with high cognitive reserve are better able to cope with and compensate for 
brain damage than those with low reserve, despite having the same amount of brain pathology, 
due to increased neuronal efficiency and greater availability of alternate brain networks and 
cognitive strategies upon which to draw. They have more cognitive strategies at their disposal, 
which enables them to withstand more “hits” without displaying clinical symptoms and 
maintaining functional processing (Andrews-Hanna et al., 2010; Barnett, Salmond, Jones, & 
Sahakian, 2006; Rajji, 2018).   
A related concept of cognitive reserve is brain reserve, which emphasizes the importance 
of certain brain features for maximal neuronal processing, including brain size, head 
circumference, synaptic count, and dendritic complexity. Individuals with high brain reserve can 
afford to lose more synapses because they have enough remaining to maintain efficient 
processing without disruption (Brickman et al., 2011; Foubert-Samier et al., 2012; Sumowski et 
al., 2014). As with cognitive reserve, brain reserve can grow with continual neuronal activity and 
stimulation (Barulli & Stern, 2013), thereby representing the underlying role of neuroplasticity. 
CCT can induce plastic changes to strengthen and maintain neuronal connections that are 
damaged or disrupted in MDD, such as the CNN (Porter et al., 2013; Preiss et al., 2013).   
 
History of Computerized Cognitive Training  
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The history of CR can be traced to World War I, when brain-damaged soldiers returning 
from combat needed cognitive rehabilitation. Neuropsychologist Alexander Luria called for a 
process-based approach, in which patients completed drills and paper-and-pencil exercises that 
were repeatedly administered (Luria, 1963, 1973, 1979).  In the 1970s, delivery of these 
exercises were made easier with the introduction of computers into the mainstream (Parente & 
Stapleton, 1997). 
By the late 1990s, non-clinicians came to recognize the potential of “brain games” or 
“brain training” for commercial use. Such programs as Cogmed (CogMed, 2016), BrainHQ 
(BrainHQ, 2017), Brain Age (BrainAge, 2012), Peak Brain Training (Peak Brain Training - 
Level Up!, 2015), and Luminosity (Luminosity) have been astronomically successful, generating 
more than $1 billion in revenue in 2012 alone and estimated to earn $6 billion by 2020 (Simons 
et al., 2016). Luminosity alone has over 50 million subscribers (Boot & Kramer, 2014). Most 
commercial programs comprise an assortment of games designed to target and train specific 
cognitive abilities.  
The brain training industry has made exaggerated claims to promote its products, such as 
“[playing the games will] improve performance on everyday tasks; will improve school, work, 
and athletic performance; [and] will delay age-related decline in memory and protect against 
other age-related conditions” (Underwood, 2016). Of note, these claims were based on studies 
that were funded by the companies themselves, thereby setting the stage for conflicts of interest, 
and were methodologically and statistically flawed, such as lacking randomization, small sample 
sizes, inferior statistical strategies, inappropriate test batteries, training platforms of questionable 
construct validity, and no or inadequate control groups.  
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In October 2014, an international group of 70 cognitive psychologists and 
neuroscientists, known as the Stanford Center of Longevity, issued a consensus statement 
denouncing the exaggerated and misleading claims made by the brain training industry (Allaire 
et al., 2014). However, soon after, in December 2014, another international group of 127 
scientists released a counterstatement in support of CCT:   
“[While] claims promoting brain games are frequently exaggerated 
and are often misleading…There is, in fact, a large and growing 
body of such evidence [which] includes dozens of randomized, 
controlled trials published in peer-reviewed journals that document 
specific benefits of defined types of cognitive training. Many of 
these studies show improvements that encompass a broad array of 
cognitive and everyday activities, show gains that persist for a 
reasonable amount of time, [and] document positive changes in 
real-life indices of cognitive health” (Data, 2014). 
 
How is it that two scientific bodies, having reviewed the same literature, came to 
conclude such widely disparate opinions (Simons et al., 2016)? Several independent, 
scientifically rigorous studies have since been published that potentially resolve the dispute. 
When it comes to CCT effectiveness, content and dose matter.  
 
Factors that Impact CCT Response 
Content 
CCT programs vary in content, such as attention training, memory training, EF training, 
working memory (WM) training, and, arguably, videogames. The conclusions drawn by the 
Stanford Consensus Group were primarily based on the findings from WM training and 
videogames, which does not discredit the benefits of other training programs. Thus, what 
training programs are effective?  
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Results from the Advanced Cognitive Training for Independent and Vital Elderly 
(ACTIVE) study, a 10-year, longitudinal study of 2,832 older adults in the United States, provide 
compelling support for PS and EF training. Participants were randomly assigned to one of four 
training groups (PS, reasoning, memory, or no contact) and completed cognitive testing and 
simulated measures of daily functioning at baseline, post-training, and at one- , five- , and ten-
year follow-ups. Each group improved on their respective cognitive ability immediately after 
training (e.g., near transfer). Yet, the largest degree of improvement was seen in the PS group 
(87% improvement) followed by the reasoning (74%) and memory (26%) groups. Gains 
persisted after 10 years for the PS and reasoning groups but dissipated within two years for the 
memory group (Rebok et al., 2014).  Near gains from PST have been reported elsewhere (Ball, 
Edwards, & Ross, 2007; Ball, Ross, Roth, & Edwards, 2013; Edwards et al., 2005; Nouchi et al., 
2013; Takeuchi et al., 2011; Vance, Fazeli, Ross, Wadley, & Ball, 2012).  
Additionally, a subset of participants from each group were given four booster sessions 
shortly before the one-year and three-year post-training mark. Yet again, improvement was most 
pronounced for the PS group. A single booster session (60-75 minutes) counteracted 4.92 months 
of age-related decline in PS (Rebok et al., 2014). To summarize, PS training resulted in the 
greatest gains, better maintenance of those gains for at least 10 years, and greater enhancement 
from a single booster session.   
The superiority of PS training is not limited to PS, with improvements shown in health, 
depressive symptoms, activities of daily living, and driving ability. Indeed, ten sessions of PS 
training resulted in (1) a 0.8% reduction in the five-year mortality rate (Wolinsky et al., 2009c), 
(2) a 26% reduction in risk of quality of life decline after five years (Wolinsky et al., 2006), (3) a 
64% greater likelihood of improvements in internal locus of control at 5 years, which was 
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positively associated with better self-rated health, fewer illnesses, and lower rates of mortality 
(Wolinsky et al., 2009d), (4) a predicted 3% reduction in expected medical expenditures 
($244/year) after one year (Wolinsky et al., 2009a), and (5) a reduction of motor vehicle 
accidents, which, in practical terms, means prolonged driving mobility, decreased risk of driving 
cessation, and improved driving safety (Ball, Edwards, Ross, & McGwin Jr, 2010). Effects on 
mood were equally astounding; PS training reduced the risk of depression onset by 38% at one-
year follow-up, whereas reasoning nor memory training resulted in these effects. Among 
individuals with depression at baseline, the risk of worsening depressive symptoms was reduced 
by 30% between years one to five (Wolinsky et al., 2009c). Additional far effects from PS 
training have been reported elsewhere (Edwards et al., 2005; Edwards et al., 2002; Lawlor-
Savage & Goghari, 2016; Nouchi et al., 2013; Roenker, Cissell, Ball, Wadley, & Edwards, 
2003),  including from the Iowa Healthy and Active Minds Study (IHAMS). IHAMS was the 
follow-up to the ACTIVE study, which tracked a subsample of 681 adults over five years. 
Among those with MDD, they found neither symptom severity nor medication status moderated 
response to PS training (Lohman et al., 2013; Wolinsky, Vander Weg, Howren, Jones, & Dotson, 
2015). In other words, PS training may be effective in improving cognition and everyday 
functioning in MDD for individuals regardless of depressive severity and medication status.  
 
Dose  
Proponents of CCT claim CCT is effective if given the correct dose. Studies have varied 
in the amount of training provided, ranging from as few as three sessions (Borella, Carretti, 
Riboldi, & De Beni, 2010) to as many as 100 (Schmiedek, Lövdén, & Lindenberger, 2010). Most 
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sessions last 30-45 minutes (von Bastian & Oberauer, 2014). Differences in dose across studies 
may explain the variability in the literature.  
Mounting evidence points to an optimum amount of 10-15 hours of training, with 
benefits plateauing or diminishing thereafter (Anguera & Gazzaley, 2015; Berry et al., 2010; 
Hoorelbeke, Koster, Vanderhasselt, Callewaert, & Demeyer, 2015; Lampit, Hallock, Suo, 
Naismith, & Valenzuela, 2015; Medalia & Richardson, 2005; Trapp, Engel, Hajak, 
Lautenbacher, & Gallhofer, 2016). Whereas insufficient training limits learning and 
neuroplasticity, overtraining may result in cognitive fatigue, loss of motivation, and boredom 
(Anguera et al., 2012; Holtzer, Shuman, Mahoney, Lipton, & Verghese, 2010; Persson, Welsh, 
Jonides, & Reuter-Lorenz, 2007). In the prolific ACTIVE study, all four training groups 
demonstrated near transfer effects following ten hours of training (Rebok et al., 2014), with other 
studies using MDD samples according to these findings (Semkovska & Ahern, 2017; Trapp et 
al., 2016; Wolinsky et al., 2009b). That said, there is also support for a dose-response 
relationship between dose and transfer gains in the literature (Alloway, Bibile, & Lau, 2013; 
Chiu et al., 2017; Choi & Medalia, 2005; Jaeggi, Buschkuehl, Jonides, & Perrig, 2008; 
Kłosowska, Blaut, & Paulewicz, 2015; Semkovska & Ahern, 2017; Valdés et al., 2017; 
Vinogradov, Fisher, & de Villers-Sidani, 2012). 
How the 10-15 hours of training are spaced is also important (Penner et al., 2012; von 
Bastian & Oberauer, 2014; Wang, Zhou, & Shah, 2014), with greater spacing resulting in greater 
transfer. To examine the effect of spacing on transfer, Wang et al. (2014) distributed twenty, 20-
minute sessions of CCT across different time intervals (two, five, ten, or twenty days) and found 
that transfer only occurred for participants who received training across twenty days.   
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Additional Factors that Impact CCT Response  
Genetic factors. Genetic factors that regulate the availability of dopamine (DA) have 
been shown to impact CCT response (Bäckman, Nyberg, Lindenberger, Li, & Farde, 2006; 
Remy & Samson, 2003; Robbins, 2003). One candidate receiving significant attention is a 
polymorphism that regulates DA in the PFC, COMT Val158Met. Carriers of the met variant have 
been correlated with greater cognitive performance, everyday functioning, and functional 
reorganization following CCT (Colzato, van den Wildenberg, & Hommel, 2014; Panizzutti, 
Hamilton, & Vinogradov, 2013; Pieramico et al., 2012; Söderqvist et al., 2012), as it is 
associated with a slower rate of DA degradation and, thus, higher levels of DA in the PFC (Witte 
& Flöel, 2012). Polymorphisms in BDNF Val66Met is another candidate receiving attention, as 
well (Enge et al., 2016; Witte et al., 2012). 
Age. Age is a significant moderator of CCT efficacy, with younger adults demonstrating 
larger and broader transfer effects than older adults (Brehmer, Westerberg, & Bäckman, 2012; 
Burke & Baldwin, 1999; Dahlin, Nyberg, Bäckman, & Neely, 2008; Heinzel et al., 2014; 
Schmiedek et al., 2010; Wass, Scerif, & Johnson, 2012). CCT has been shown to amerliorate 
depressive symptoms and everyday functioning for people of all ages, yet the degree of 
improvement diminishes with age (Motter et al., 2016b). Age-related differences in CCT have 
been surmised to reflect differential constraints in neuroplasticity, of which younger adults have 
higher potential (Dahlin et al., 2008). This is supported by studies that show that (1) younger 
adults progress further and faster through adaptive training than their older counterparts (Heinzel 
et al., 2014) and (2) younger adults receive near and far benefits from CCT, whereas the benefits 
for older adults are restricted to near benefits (Dahlin et al., 2008; Heinzel et al., 2014). That 
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said, some studies found comparable degrees of improvement (Karbach & Verhaeghen, 2014; Li 
et al., 2008) or greater improvement in older adults (Zinke et al., 2014).   
Combined treatment. CCT, when combined with another treatment, is more effective in 
ameliorating MDD symptoms than CCT alone (Koster, Hoorelbeke, Onraedt, Owens, & 
Derakshan, 2017). Adding CCT to anti-depressant medication, psychotherapy, or transcranial 
direction current stimulation has been shown to enhance treatment response in MDD (Bamidis et 
al., 2015; McGurk, Twamley, Sitzer, McHugo, & Mueser, 2007; Park et al., 2014; Styliadis, 
Kartsidis, Paraskevopoulos, Ioannides, & Bamidis, 2015; Teasdale, Segal, & Williams, 1995). 
Therefore, CCT is a versatile augmentative treatment that does not contaminate nor interfere 
with other antidepressant treatments.   
Baseline cognitive and brain reserve. There is equivocal support for the “Matthew 
Effect” or the “rich-get-richer effect” in the CCT literature (Jaeggi, Buschkuehl, Shah, & 
Jonides, 2014; Karbach & Unger, 2014; Shah, Buschkuehl, Jaeggi, & Jonides, 2012; Titz & 
Karbach, 2014; von Bastian & Oberauer, 2014), the idea that individuals with higher cognitive or 
brain reserve benefit more from CCT because they have greater brain capacity and cognitive 
resources to draw upon. It has been argued the Matthew Effect is only applicable to strategy-
based training but not process-based training(Sandberg, 2014). 
Alternatively, others suggest that CCT is more effective for lower functioning individuals 
because they have more to gain and a higher ceiling for improvement (Baniqued et al., 2014; 
Whitlock, McLaughlin, & Allaire, 2012; Zinke et al., 2014). Referred as the “Compensation 
Effect” (Strobach, Frensch, Müller, & Schubert, 2012), it may explain why individuals with 
learning disabilities, dementia, attention deficit hyperactivity disorder, stroke, acquired brain 
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injury, and substance abuse show greater transfer than their healthy counterparts (von Bastian & 
Oberauer, 2014).  
Race as Unexplored Factor. To our knowledge, no study has been published that 
examined racial differences in CCT response. Studies on other interventions for depression give 
rise to believe that these differences may exist; Asians have been found to benefit less from 
antidepressant treatment than their White counterparts (Ng et al., 2013; Novick et al., 2013; Tsai 
et al., 2010). Access to and utilization of mental healthcare have been posited as key contributing 
factors (Augsberger, Yeung, Dougher, & Hahm, 2015; Gonzalez et al., 2010; Sue, Cheng, Saad, 
& Chu, 2012). There is evidence to suggest that Asians have a higher tendency to somatize their 
emotional distress (Novick et al., 2013), resulting in a larger number of misdiagnoses (Borowsky 
et al., 2000; Shao, Richie, & Bailey, 2016). This, in turn, may contribute to receiving improper 
and ineffective treatment as well as a general mistrust in the medical system (Noël & Whaley, 
2012). Differences in communication (e.g., language and racial/ethnic mismatch between patient 
and provider) likely compound the feelings of mistrust (Leong & Lau, 2001) 
 Notwithstanding, patient-based and cultural factors may also explain racial disparities in 
antidepressant treatment response. Asians have been shown to be less likely to seek mental 
health treatment (Chen, Sullivan, Lu, & Shibusawa, 2003; Lee, Martins, Keyes, & Lee, 2011) 
and to be less compliant with their medication regime (Novick et al., 2015), potentially because 
it is discordant with their relational-interdependent culture that emphasizes “family hierarchy, 
emotional restraint, [and] avoidance of shame” (Shea & Yeh, 2008). Seeking mental health 
treatment outside the family has traditionally been perceived as a violation of the family 
hierarchy and as a mark of stigma and shame to the family, which negatively affects their 
standing in their community (Leong & Lau, 2001). Consequently, emphasis is placed on self-
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agency (“fixing one’s own problems”) and turning inwards to family members for help (Leong & 
Lau, 2001).  
 However, CCT is syntonic with the cultural values of self-agency and discretion as it 
discretely delivered on a mobile device, does not require interaction with others (thereby 
eliminating the potential shame of people finding out), and because performance is based entirely 
on one’s own efforts. The fact that CCT is rooted within the gaming culture, which originated in 
and is exceedingly popular among Asian groups (Messner, 2019), may further appeal to this 
population.    
 
Scientific Shortcomings in the Literature 
While the benefits of CCT are encouraging, casting doubt are several issues and scientific 
shortcomings in the literature. (1) Initial studies on CCT were funded by brain training 
companies (Data, 2014), giving rise to conflicts of interest. (2)  Previous studies were 
statistically and methodologically flawed, such as failing to account for baseline differences, 
small sample sizes, lack of randomization, inferior statistical strategies, inappropriately-sized test 
batteries, training platforms of questionable construct validity, and/or absence of longitudinal 
follow-ups (Bogg & Lasecki, 2015; Boot et al., 2013; Dougherty, Hamovitz, & Tidwell, 2016; 
Moreau & Conway, 2014; Moreau, Kirk, & Waldie, 2016; Noack, Lövdén, & Schmiedek, 2014; 
Tidwell, Dougherty, Chrabaszcz, Thomas, & Mendoza, 2014). (3) The biggest criticism is that 
many studies did not include a control group (Jaeggi et al., 2008; Rudebeck, Bor, Ormond, 
O’Reilly, & Lee, 2012) or used a control group that was inappropriate to infer causality, such as 
waitlist control groups. Waitlist control groups are most commonly used in the literature 
(Åkerlund, Esbjörnsson, Sunnerhagen, & Björkdahl, 2013; Basak, Boot, Voss, & Kramer, 2008; 
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Berry et al., 2010; Finn & McDonald, 2011; Von Ah et al., 2012), but are inadequate in 
controlling for statistical regression to the mean, systematic selection biases, and non-specific 
effects (Boot et al., 2013; Simons et al., 2016). Further complicating matters is that positive 
transfer effects have been more commonly observed in passive control studies than in active 
control studies (Simons et al., 2016), thereby speaking to the possibility of placebo effects. 
Recent attempts have been made to include an active control condition, such as watching an 
educational video (Mahncke et al., 2006), completing crossword puzzles (Hardy et al., 2015), 
and playing nonviolent videogames (Green & Bavelier, 2012; Green, Sugarman, Medford, 
Klobusicky, & Bavelier, 2012). However, while technically “active,” none are as challenging, 
interesting, or as sufficiently motivating as CCT. 
 
Types of Nonspecific Factors  
Participant expectancy. Raising alarm is the potential confound of participant 
expectancy in CCT research, the idea that subjects alter their behavior based on their 
expectations of the result (Foroughi, Monfort, Paczynski, McKnight, & Greenwood, 2016). 
Within the context of CCT, the mere anticipation of improvement leads to actual improvement, 
independent of actual efficacy. Brilliant marketing from commercial brain training companies 
explicitly promise cognitive improvement, with effective and pithy taglines as “Stay sharp, build 
confidence, and boost productivity” (Elevate, 2014),  “Think faster. Focus better. Remember 
more” (BrainHQ, 2017), and “an evidence-based intervention for improved working memory” 
(CogMed, 2016). A national survey of 1,200 consumers revealed that most believed that brain 
training “improves memory,” sharpens intellectual skills,” “helps improve my attention span,” 
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“helps me think faster,” “increases IQ,” and “prevents memory loss” regardless if they have had 
personal experience with brain games (David & Gelfeld, 2014).  
The manner in which participants are recruited for brain training research introduces 
expectancy effects, as well. Overt recruitment methods (i.e., the expected benefits of training are 
stated or implied) may lead to self-selection bias, such that individuals who expect positive 
results will be overrepresented in any sample of participants (Foroughi et al., 2016). A meta-
analysis by Au et al. (2015) revealed that 11 out of 19 studies used overt recruitment methods 
that went as far as to suggest potential improvement (e.g., “brain training study for cognitive 
enhancement”).  
Lastly, the type of research design can elicit differential expectancy effects. Participants 
in a no-contact waitlist group or a passive control group may expect fewer results because they 
are not “doing anything” or are minimally engaged (Boot et al., 2013). To that end, are the 
positive findings due to systematic differences in expectancy?   
Engagement. Another factor drawing question into the unique benefits of CCT is 
engagement, or the ability to capture and sustain one’s interest (Wiebe, Lamb, Hardy, & Sharek, 
2014). Critics contend CCT is effective insofar as it is a stimulating activity and thus any 
stimulating activity is capable of producing similar results. This idea aligns with the Environment 
Enrichment Hypothesis, which states that participation in any stimulating and challenging 
activity – whether it be cognitive, physical, or social – is cognitively salubrious (Voss et al., 
2013). CCT promotes engagement by using colorful, attractive, and interesting animation 
(aesthetics), by making the training fun and game-like (satisfaction) and user friendly (perceived 
usability), and by creating challenging, yet achievable tasks that absorb the player’s attention 
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(focused attention or flow) (Wiebe et al., 2014). To that end, are the positive findings strictly the 
result of social and/or cognitive engagement?  
Motivation. Related to the construct of engagement is motivation, which also confounds 
CCT efficacy. Whereas engagement is a transient experience, motivation is a stable trait or 
worldview that can influence cognitive performance (Wiebe et al., 2014). Critics contend that the 
positive results of CCT reflect selection bias and motivational factors since motivated individuals 
are more likely to participate in unpaid research (Bruno & Fiorillo, 2012) and complete training 
protocols (Brehmer et al., 2012; Jaeggi et al., 2014). Conversely, less motivated individuals are 
more likely to give up when challenged and to drop out of the study (Donkin & Glozier, 2012; 
Fan & Wolters, 2014). 
The common use of motivational reinforcers in most CCT platforms also confounds 
treatment efficacy. Motivational reinforcers are tools embedded within a game to increase 
motivation (Dörrenbächer, Müller, Tröger, & Kray, 2014), such as persistent scoring (a score is 
generated after the successful completion of a level), tutorials and scaffolding, theming (games 
are presented within a specific genre, e.g., sports-, medieval fantasy-, military-themed), and 
immediate feedback (Katz, 2017). Several studies have shown the singular impact of 
motivational reinforcers on cognitive performance (Dörrenbächer et al., 2014; Duckworth, 
Quinn, Lynam, Loeber, & Stouthamer-Loeber, 2011; Katz, Jaeggi, Buschkuehl, Stegman, & 
Shah, 2014; Lumsden, Edwards, Lawrence, Coyle, & Munafò, 2016; Zou et al., 2010). Differing 
only in gaming elements, Dörrenbächer et al. (2014) found that participants who were presented 
with motivational reinforcers on a task-switching game showed greater improvement in 
cognitive flexibility (near transfer) and PS (far transfer) than those without motivational 
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reinforcers. To that end, are the positive findings reflective of systematic differences in 
motivation?  
 Novelty. Some claim that the cognitive benefits of CCT can be ascribed to the 
participation of a new or unusual activity (Schomaker, 2015), such as learning a new language 
(Bugos & DeMarie, 2017; Park & Poo, 2013; Schomaker, 2015), musical instrument (Hanna-
Pladdy & MacKay, 2011; Klein, Mok, Chen, & Watkins, 2014), or taking a different route home 
(Niederstrasser, Hogervorst, Giannouli, & Bandelow, 2016). Novely alone can impact cognitive 
performance, independent of social engagement or task complexity. In a sample of production 
workers, Oltmanns et al. (2017) found that workers with more work-related changes (e.g., 
recurrently confronted with new work tasks that required mastery) demonstrated greater PS, 
WM, and gray matter volume than those who did not undergo work-related changes. Because 
CCT is itself a novel activity for most people and the training changes repeatedly, it begs the 
question: are the positive findings due to systematic differences in exposure to novelty?   
 
Current study  
 To summarize, individuals with MDD present with a variety of cognitive symptoms, 
notably in EF, that persist following treatment. CCT has been shown to improve cognition in 
multiple clinical populations. The type and amount of CCT prescribed appears to matter, with 
several national, large-scaled studies supporting 10 hours of PS training to improve cognitive, 
affective, and functional outcomes. Young people typically benefit more from CCT than older 
people due to their greater capacity for neuroplasticity. However, there remains a major issue 
that challenges the validity of CCT – are the cognitive benefits of CCT actually attributable to 
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nonspecific factors? Most CCT studies have used a waitlist control or a passive active control, 
which does not control for expectancy, engagement, motivation, and novelty.   
 To address these shortcomings, we devised an eight week, double-blind, randomized 
controlled trial for young adults (ages 18-29) with mild to moderate depressive symptoms who 
were randomized to either a PS/EF group (treatment group) or a verbal ability group (active 
control group).  Participants were evaluated at baseline, at which time they downloaded a phone-
based application (platform) containing their respective games, and reevaluated eight weeks 
later. The groups differed only with respect to the content, or “active ingredient,” of the games. 
Both groups were instructed to train for at least 15 minutes each day, five days a week, for eight 
weeks, thereby controlling for training load. Both groups spent an equal (and limited) amount of 
time interacting with the research team, thereby controlling for social engagement.  Lastly, all 
games were delivered digitally, scaled in difficulty, and provided motivational reinforcement 
upon performance, thereby making the active control as visually appealing, cognitively 
challenging, motivating, and interesting as the treatment group.  
 
Aims and Hypotheses 
Aim 1. To determine whether PS/EF training leads to greater cognitive improvement than the 
active control.  
 Hypothesis 1. After eight weeks of training, the PS/EF group will demonstrate 
significantly greater improvements in PS (as measured by WAIS-IV Coding, combined D-KEFS 
Color Naming and Word Reading, and D-KEFS Number Sequencing) than the active control 
group.  
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 Hypothesis 2. After eight weeks of training, the PS/EF group will demonstrate 
significantly greater improvements in EF (as measured by D-KEFS Letter Fluency, D-KEFS 
Number-Letter Sequencing, and D-KEFS Inhibition) than the active control group. 
 Hypothesis 3. After eight weeks of training, the PS/EF group will demonstrate 
significantly greater improvement in auditory attention (as measured by WAIS-IV Digit Span 
Forward) than the active control group. 
 Hypothesis 4. After eight weeks of training, the PS/EF group will demonstrate 
significantly greater improvements in verbal learning (CVLT-II Total Learning), short-term 
recall (CVLT-II Short Delay Free Recall) and long-delay recall (CVLT-II Long Delay Free 
Recall) than the active control group.  
 
Aim 2. To explore whether demographic, clinical, and treatment utilization factors differentially 
impact CCT response on magnitude of cognitive change. 
 Hypothesis 1. After eight weeks of training, Asians will demonstrate significantly greater 
cognitive improvement than Whites.  
 Hypothesis 2. After eight weeks of training, individuals taking medication and/or 
receiving psychotherapy for their depressive symptoms (i.e., concurrent treatment) will 
demonstrate significantly greater cognitive improvement than those not receiving treatment.  
 Hypothesis 3. After eight weeks of training, individuals with higher baseline depressive 
severity will demonstrate significantly greater cognitive improvement than those with lower 
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Forty-six young adults (ages 18-29) with mild to moderate depressive symptoms were 
recruited. Participants were recruited through online advertisements, email listserv 
announcements, and flyers in the community.  Eligibility was determined with a clinical 
interview, conducted by one of two trained doctoral students. Inclusion criteria included 18-29 
years old (inclusive), English proficiency, HDRS score of at least 10, daily access to a 
smartphone or tablet with internet connection for the study duration, WTAR score of at least 85, 
and willing and able to complete mood and neuropsychological testing. Exclusion criteria 
included lack of English proficiency, active suicidal intent at time of screening, past or current 
diagnosis of a major psychiatric condition (schizophrenia, schizoaffective disorder, psychosis, 
bipolar I or II), neurological condition (seizures/epilepsy, multiple sclerosis, traumatic brain 
injury, or stroke), thyroid disease, cancer, and/or HIV/AIDS, regular play of online brain games 
(e.g., Luminosity, Brain HQ, or Happy Neuron) or non-fluency verbal games (e.g., crossword 
puzzles), and history of illicit drug use (e.g., cocaine, heroin, amphetamines, barbituates, 
hallucinogens, inhalants) or alcohol abuse or dependence in the past 6 months. Participants were 
excluded if they used marijuana more than 2 times in the past 6 months. Detailed 
inclusion/exclusion criteria are described in Table 1. 
Data were collected from July 2016 to December 2017. The study was approved by the 
Institutional Review Board at Queens College, City University of New York.  
 
Procedures 
Participants provided informed consent and were administered a comprehensive 
neuropsychological evaluation by a trained doctoral student. Participants were randomized into 
the treatment group (PS/EF group) or the active control group (verbal group). Both evaluator and 
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participant were blind to group assignment; a member of the research team, who was otherwise 
unaffiliated with the current study, was solely responsible for randomizing participants. With 
assistance from research personnel, participants installed a commercially available cognitive 
training application onto their smartphones that comprised 5 PS/EF games or 5 non-fluency 
verbal games. All games scaled in difficulty, provided immediate feedback on performance, and 
presented on an identical user interface. Participants programmed reminder notifications on their 
phones or tablets to train daily at the time of installation, but the times chosen were not binding. 
Both groups were instructed to train for at least 15 minutes a day, five days a week, over the 
course of eight weeks, amounting to at least 10 hours of training. After eight weeks, participants 
were re-evaluated and compensated $60 for completing the study. The pilot  study was funded by 
the the Doctoral Student Research Grant Program at CUNY and the Professional Staff Congress- 
CUNY Research Award Program.  
 
Training Groups  
 Participants were randomized into one of two groups, the PS/EF group or the verbal 
training group. Everyone installed the same commercially-available cognitive training 
application onto their smartphone or tablet, difffering only in training content. 
 
PS/EF Group (Treatment Group) 
  The PS/EF group was given five games that tapped into PS and EF. They had the option 
to play all five games or to pick and choose their preferred games. A description of each game is 
provided below (Peak Brain Training - Level Up!, 2015):  
• Must Sort – Sort the items correctly by tapping on the left or right side of the screen. 
Wrongly scored items give you a time penalty. 
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• Face Switch – Determine if the woman on the top card is happy or if the man on the 
bottom card is wearing glasses. 
 
• Refocus – Determine if the number on the top card is even or if the letter on the bottom 
card is a vowel. 
 
• Tunnel Trance – Compare the shape on the screen with the one displayed two back. 
Memorize the second shape. Does the current shape match the one from two steps before 
that? 
 
• True Color – A word and a color will appear on a card. Determine if the word at the top 
matches the color of the word on the bottom. Ignore the meaning of the word at the 
bottom and focus just on its color. 
 
Verbal Group (Active Control) 
  The verbal group was given five games that tapped into non-fluency verbal abilities. As 
with the treatment group, they could train on all five games or only those they preferred. A 
description of each game is provided below (Peak Brain Training - Level Up!, 2015): 
• Word-A-Like – Find words that are associated to the target. Tap the trashcan button to 
remove all letters from selected word. If stuck, tap skip button to move to next round. 
 
• Word Pairs – Pair words according to the rule by dragging and dropping clouds to 
combine. 
 
• Word Path – Create words to connect the yellow end points. Words must be spelled left 
to right or top to bottom. Words must use letters already placed or cover a yellow 
endpoint. 
 
• Word Fresh – Create words by swiping through adjacent letters. Release to complete. 
Words can be created in any direction. 
 
• Babble Bots – Create words of three letters or more by tapping the letters and pressing 
“submit.” If you make a mistake you can erase letters with the “delete” button. Create 
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 Mood and cognition were assessed with a variety of clinical measures, rating scales, and 
neuropsychological tests. The neuropsychological battery assessed PS, EF, attention, and 
learning and memory. Whenever available, alternate forms of the tests were given at post-
training. Unless otherwise specified, each test was given at baseline and at eight weeks.  
Mood Measures  
MDD module of the Anxiety Disorders Interview Schedule – Fourth Edition (ADIS-
IV). This is a highly-structured diagnostic tool that was administered by the examiner. In a yes or 
no format, participants were asked whether they had experienced each depressive criterion nearly 
every day for the past two weeks. Scores range from 0-9, with higher scores indicative of greater 
number of depressive symptoms present (Brown, Barlow, & DiNardo, 1994). 
Hamilton Depression Rating Scale (HDRS). The HDRS is an interviewer-rated scale of 
depression and depression severity (Kobak, 2010). It comprises 17 items that map onto the 
diagnostic criteria of MDD as well as the symptoms commonly associated with MDD. Cut-off 
scores were classified as normal (0-9), mild depression (10-13), moderate depression (14-17), 
and severe depression (>17). A minimum score of 10 was required for eligibility, with sadness 
and/or anhedonia having been endorsed. 
Beck Depression Scale – Second Edition (BDI-II). The BDI-II is a self-report measure 
of depression severity (Beck, Steer, & Brown, 1996). Participants rated the extent to which they 
had experienced the affective, cognitive, and somatic symptoms of depression over the past two 
weeks. Cutoff scores were classified as: within normal limits (0-13), mild depression (14-19), 
moderate depression (20-28), and severe depression (29-63).  
 
PS Measures 
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WAIS-IV Coding. Coding is a measure of PS and graphomotor speed. Participants were 
presented with a printed grid of numbers paired with a unique symbol. Directly below the printed 
key were rows of numbers with blank boxes. Participants were given 120 seconds to draw the 
symbol that corresponded with the number as quickly and as accurately as possible. Scores 
represent the total number of blank boxes correctly completed within the time limit, with higher 
scores indicative of better performance (Wechsler, 2014).  
D-KEFS Trail Making Test - Number Sequencing. This subtest is a measure of visual 
search, perceptual/motor speed, and PS. Participants connected 25 encircled numbers that were 
dispersed across the page. They had to connect the numbers in numerical order as quickly as 
possible. Scores represent the total completion time in seconds, with smaller values indicative of 
faster performance (Delis, Kaplan, & Kramer, 2001).   
 D-KEFS Color-Word Interference - Color Naming and Word Reading. This is a 
composite that measures PS and automatic processing. For Color Naming, participants were 
presented with rows of different colored boxes. Participants named the colors aloud as quickly as 
possible. For Word Reading, participants read aloud the words, “blue,” “red,” and “green” as 
quickly as possible. Scores represent the combined completion time in seconds on both trial, with 
lower scores indicative of faster performance (Delis et al., 2001).  
 
EF Measures  
D-KEFS Letter Fluency. This subtest measures verbal initiation and retrieval. 
Participants were given one minute to list as many words that start with the target letter. The 
standard form was given at baseline and the alternate form was given at the re-evaluation. Scores 
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represent the total number of correct and novel responses generated across three trials, with 
higher scores indicative of better performance (Delis et al., 2001).   
D-KEFS Trail Making Test - Number-Letter Sequencing. This subtest measures 
cognitive flexibility, inhibition, WM, attentional set-shifting, and PS. Participants were presented 
with 25 encircled numbers and letters dispersed across the page. They had to connect the 
numbers and letters in alphanumerical order as quickly as possible. Scores represent the total 
completion time in seconds, with smaller values indicative of faster performance (Delis et al., 
2001).   
D-KEFS Color-Word Interference Test – Inhibition. This is a measure of inhibitory 
control. Participants were presented with words of different colors (blue, red, green) that were 
printed in an incongruent ink color (e.g., the word GREEN was printed in RED ink). Participants 
had to name the color ink. Scores represent the total amount of time (in seconds) to name the 
color ink of all the words, with lower scores indicative of faster performance (Delis et al., 2001).  
 
Additional Cognitive Measures  
WAIS-IV Digit Span Forward (DSF). DSF is a measure of auditory attention. 
Participants were aurally presented a string of numbers, which they then had to repeat in the 
same order. The strings of numbers increased in length. Scores represent the total number of 
strings that were accurately repeated (Wechsler, 2014).  
California Verbal Learning Test- Second Edition (CVLT-II). This test measures 
verbal learning and memory (Delis, Kramer, Kaplan, & Ober, 2000). Three scores were 
generated,  Total Verbal Learning, Short-Delay Free Recall, and Long-Delay Free Recall. The 
examiner reads a list of 16 words aloud five times. After each trial, participants were asked to 
  37 
 
recall as many of words as they could remember. The Total Learning Score represents the total 
number of correct words recalled across five trials. Following the presentation of a distractor 
trial, participants are instructed to recall the words from the original list. The Short-Delay Free 
Recall score is the total number of words correctly recalled following the distractor. After a 20-
minute delay, participants were instructed again to recall the words from the original list. The 
Long-Delay Free Recall score is the total number of words correctly recalled following a 20-
minute delay.  
Wechsler Test of Adult Reading (WTAR). The WTAR provides an estimate of 
premorbid intellectual functioning. Participants read aloud a list of phonetically irregular words 
that increased in difficulty. Scores ranged from 0-50, representing the total number of correctly 
pronounced words (Wechsler, 2001). The WTAR was administered at baseline only. 
 
Engagement  
The User Engagement Scale (UES) was used to measure participants’ level of 
engagement with the training application, which they completed at week eight. The scale ranged 
from (1) strongly disagree to (7) strongly agree. Participants rated the quality of their experience 
along four dimensions; satisfaction (how fun or novel were the games and the likelihood of 
playing again?), aesthetics (how visually appealing were the games?), perceived usability (was 
the interface user-friendly?), and focused attention (how immersive were the games?). A total 
engagement score was computed, with higher scores indicative of greater engagement with the 
training application (Wiebe et al., 2014). 
 
Statistical Analyses  
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 Prior to testing specific hypotheses, data were imputed using multiple imputation (MI) to 
account for any missing values over the course of the study. MI is a simulation-based statistical 
procedure that assumes that missing values are missing at random. Relative to ad hoc 
approaches, MI reduces bias and preserves sample size and statistical power by including data 
that would otherwise be excluded. MI uses a participant’s available data to predict his/her 
missing value in three steps. First, MI creates multiple complete versions of the dataset (e.g., m 
number of complete datasets) to “fill in” missing values. Five imputed datasets (m=5) were 
created based on previous findings that 3 to 5 imputations were adequate in producing excellent 
results when 20% or less of the data were missing (Schafer & Graham, 2002). In the present 
study, 12.4% of the data were missing, indicating that 5 imputations should be adequate. The 
simulated replacement values are expected to vary across datasets due to the uncertainty of the 
prediction of the missing values. Second, each of the five imputed datasets were analyzed using 
standard statistical techniques (e.g., t-tests and multiple regression). Third, results from each of 
the five analyses were pooled and averaged to produce an overall estimate, which accounts for 
the between-imputation and within-imputation variability (McCleary, 2002).  
 To test the MI assumption that data were indeed missing at random in the current study, 
baseline characteristics between completers and non-completers of the training program were 
analyzed using Chi-square Test of Independence and the Independent Samples T-test.  
 Descriptive statistics were calculated for all demographic, clinical, and 
neuropsychological characteristics for the entire sample and for each training group (PS/EF and 
verbal). Means and standard deviations were computed to describe continuous variables, while 
frequencies and percentages were used for categorical variables. Chi-square Test of 
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Independence and the Independent Samples T-test were used to evaluate baseline differences 
between training groups.  
 Because the purpose of this pilot study was exploratory in nature, the decision was made 
to analyze the effect of CCT on individual outcome measures than creating a composite for each 
cognitive domain. While this method increases the chances of a Type I error, it was intended to 
generate hypotheses for future research and to assess whether the results make theoretical sense. 
Moreover, each outcome encapsulates a different aspect of the cognitive domains it meaures. 
 
Aim 1 
 Prior to conducting regression analyses, change scores for all clinical and 
neuropsychological variables from week 0 and week 8 were calculated.  Simultaneous (or forced 
entry) multiple linear regression was used to test for differences between groups in change 
scores. Assumptions for multiple linear regression were met, including linearity between the 
independent and dependent variables, multivariate normality, no multicollinearity, and 
homoscedasticity (Osborne & Waters, 2002). Baseline scores of the dependent variable and 
training group were entered as covariates. Covariates were centered at their respective means to 
more easily interpret the effect of training on change scores from week 0 to week 8. Effect sizes 
of changes scores were calculated using Cohen’s d. 
 
Aim 2 
 To determine whether race, clinical, and treatment factors impact CCT response, 
simultaneous (or forced entry) multiple linear regression was used to test for differences between 
groups in change scores. Differences in changes scores were compared between Asians and 
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Whites as well as between individuals receiving concurrent treatment for their depressive 
symptoms versus not. Depressive severity was retained as a continuous variable. Baseline scores 
of the dependent variable and group were entered as covariates. For race and concurrent 
treatment analyses, baseline WTAR score was additionally entered as a covariate due to 
observed differences between groups.  





 The screening process for the study is depicted in Figure 1. A total of 248 individuals 
were screened for the study, with 176 deemed ineligible and 72 eligible. Of the 72 eligible, 46 
enrolled and 26 declined to participate. Those who declined were students who were merely 
interested in satisfying a Psychology 101 course requirement of participating in a psychological 
study for at least one hour.  
 
Baseline charachteristics of completers versus noncompleters 
  Group comparisons are shown in Table 2. Individuals who completed the study 
demonstrated significantly stronger performance on D-KEFS Number-Letter Sequencing 
(t(44)=2.31, p=.026), CVLT Total Learning (t(44)=-2.32, p=.025), and CVLT Short Delay 
Recall (t(44)=12.51, p=.033) than non-completers at baseline. There were no significant 
differences between completers and non-completers on demographic, clinical, and all other 
cognitive variables.  
 
Baseline characteristics of CCT groups 
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Sample characteristics of the 46 participants are shown in Table 3. The mean age was 21.0 
(SD=3.68) years old, with 71.7% of the participants female and 28.3% male. The mean number of 
years completed in school was 14.2 years (SD=1.91). In terms of race and ethnicity, 45.7% of the 
sample identified as White, 4.2% as Black, 28.3% as Asian, 13.0% as Hispanic, and 8.7% as 
Other. Most of the participants in the sample (60.9%) reported playing no more than two hours 
of videogames per week. The mean level of depressive severity fell in the moderate range on 
both examiner-rated (HDRS; M=16.3, SD=5.54) and self-reported measures (BDI-II; M=23.0, 
SD=11.58). The mean level of functional limitations was 15.2 (SD=6.66) out of a possible score 
of 30, with higher scores indicative of greater impairment. 
Of the 46 participants, 25 were randomized to the PS/EF group and 21 to the verbal 
group. There were no significant differences between groups on demographic, clinical, or 
neuropsychological variables, except for functional limitations. The verbal group reported 
significantly greater functional limitations at baseline than the PS/EF group (t(44)=3.37, 
p=.002). 
 
Engagement and minutes trained by CCT group  
  Group comparisons of mean training time and engagement are shown in Table 4. 
There was no significant difference in mean training time between groups (U=197.5, 
p=.152). The PS/EF group trained an average of 138 minutes (SD=85.9) and the verbal group 
trained an average of 281 minutes (SD=266).  
 Training groups did not significantly differ on subscales of engagement, including 
Focused Attention (t(44)=.11, p=.909), Perceived Usability (t(44)=-.91, p=.362), Aesthetics 
(t(44)=1.12, p=.265), and Satisfaction (t(44)=.65, p=.593). 
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Eleven participants (23.9% of the sample) withdrew before the end of the study, 
with six from the PS/EF group and five from the verbal group. 
 
Aim 1   
 Results are shown in Tables 5 and 6.  
 
Hypothesis 1: PS 
 The degree of improvement on Coding was significantly greater for the PS/EF group than 
the verbal group (β=6.70, t(42)=2.37, p=.02). The PS/EF group improved on Coding by an 
additional 6.70 points than the verbal group, corresponding to an effect size of d=-.449. Baseline 
SDS score was entered as a covariate given the significant difference between training groups 
(t(44)=3.37, p=.002); the degree of improvement on Coding continued to be significantly greater 
for the PS/EF than the verbal group after additionally adjusted for baseline SDS score (β=8.00, 
t(41)=2.52, p=.01). 
The degree of improvement on CNR did not significantly differ between groups (β=.24, 
t(42)=.49, p=.63, d=-.19) nor when additionally adjusted for baseline SDS score (β=.29, 
t(41)=.48, p=.63).  
 The degree of improvement on Number Sequencing did not significantly differ between 
groups (β=-1.26, t(42)=-.98, p=.33, d=.011) nor when additionally adjusted for baseline SDS 
score (β=-1.40, t(41)=-.96, p=.34).  
 
Hypothesis 2: EF   
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 The degree of improvement on Number-Letter Sequencing was significantly greater for 
the PS/EF group than the verbal group (β=-10.0, t(42)=-3.04), p= <.001). The PS/EF group 
improved 10.0 seconds faster than the verbal group, corresponding to an effect size of 0.41. The 
mean difference remained significant after additionally adjusted for baseline SDS score (β=-8.85, 
t(41)=-2.43, p=.02).  
 There was a nonsignificant trend towards greater improvement for the PS/EF group than 
verbal group on Inhibition (β=-3.93, t(42)=-1.68, p=.09, d=.37) and when additionally adjusted 
for baseline SDS score (β=-2.15, t(41)=-.84, p=.40). 
 Training groups did not significantly differ on Letter Fluency change scores (β=2.14, 
t(42)=.76, p=.45) nor when additionally adjusted for baseline SDS score (β=1.81, t(41)=.56, 
p=.57).  
 
Hypothesis 3: Attention 
 The degree of improvement did not significantly differ between CCT groups on DSF (β=-
.06, t(42)=-.07, p=.94) nor when additionally adjusted for baseline SDS score (β=-.54, t(42)=-
.64, p=.53). 
 
Hypothesis 4: Learning and Memory 
 The degree of improvement did not significantly differ between groups on CVLT-II Total 
Learning (β=1.16, t(42)=.53, p=.59), Short Delay Free Recall (β=-2.53, t(42)=-.95, p=.34), and 
Long Delay Free Recall (β=.56, t(42)=1.0, p=.32).  
 
Aim 2 
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Hypothesis 1 
 Baseline characteristics by race. Results are shown in Table 7. Thirteen participants 
identified themselves as Asian and 21 participants identified themselves as White. No significant 
differences were observed on demographic characteristics between racial groups. There was a 
nonsignificant trend of Whites being more likely to be in psychotherapy than Asians (X2 =2.806, 
p=0.094), but no significant difference between groups in taking antidepressant medication (X2 
=1.435, p=0.231). On mood measures, Asians reported significantly lower depressive severity on 
the BDI-II (M=15.7, SD=5.6) than Whites (M=27.2, SD=11.9) (t(32)=3.27, p=.003), but the 
difference on the HDRS was insignificant (t(32)=1.66, p=.107). On cognitive measures, Asians 
scored significantly lower on the WTAR (t(32)=2.76, p=.010) and on DSF (t(32)=2.87, p=.007) 
than Whites. No significant differences were observed on functional limitations and all other 
cognitive measures.  
 
 Engagement and minutes trained by race. Results are shown in Table 8. No 
significant differences between Asians and Whites were found in mean minutes trained 
(t(32)=.66, p=.514), engagement (t(32)=0.923, p=0.365), and attrition rates (Χ2 (1, 
N=34)=.200, p=.655). Four Asians (30.8% of the subsample) and five Whites (23.8% of the 
subsample) dropped out before the end of the study. 
 
 Effect of race on regressed change scores. Results are shown in Tables 9 and 10.  
  PS. There was a non-significant trend in the opposite direction that the degree of 
improvement was lower for Asians than Whites on Coding (β=-6.249, t(32)= -1.725, p=.084, 
d=.806) and CNR (β=-1.039, t(32)= -1.714, p=.093, d=.568), when adjusted for respective 
baseline score. When additionally adjusted for WTAR score, the non-significant trend persisted 
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on Coding (β=-7.165, t(32)= -1.713, p=.087) but dropped for CNR (β=-.565, t(32)= -.748, 
p=.466). The degree of improvement on Number Sequencing did not significantly differ between 
groups (β=2.336, t(32)= 1.197, p=.235, d= -.143). 
 EF. There were significant differences between Asians and Whites on two out ofthree 
measures of EF. The degree of improvement was significantly lower for Asian than Whites on 
Letter Fluency (β=-7.569, t(32)= -2.065, p=.039, d=.378) and Number-Letter Squencing 
(β=7.894, t(32)= 2.431, p=.016, d=-.275), when adjusted for respective baseline scores. When 
additionally adjusted for WTAR, the degree of improvement continued to be significantly lower 
for Asians than Whites on Letter Fluency (β=-9.702, t(32)= -2.365, p=.018) and Number-Letter 
Squencing (β=12.516, t(32)= 3.643, p=.000). No significant difference was observed between 
groups in mean change scores of Inhibition (β=.075, t(32)= .023, p=.982, d=.170).  
 Attention. The magnitude of improvement on DSF did not significantly differ between 
Asians and Whites (β=.684, t(32)= .626, p=.533, d=-.464). 
 Learning and Memory. The magnitude of improvement did not significantly differ 
between Asians and Whites on CVLT-II Total Learning  (β=-2.564, t(32)= -.985, p=.325, 
d=.138), CVLT-II Short Delay Free Recall (β=-2.856, t(32)= -.784, p=.433, d=.288), and CVLT-
II Long Delay Free Recall (β=-.127, t(32)= -.196, p=.846, d=.067).  
 
Hypothesis 2 
 Baseline characteristics by concurrent treatment. Results are shown in Table 11. At 
baseline, 11 participants were receiving concurrent pharmacological and/or psychotherapy for 
their depressive symptoms and 35 were not receiving any form of treatment. Participants 
receiving concurrent treatment were significantly older (t(44)=-2.42, p=.02). In terms of 
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cognitive variables, participants receiving concurrent treatment scored significantly higher on the 
WTAR (t(44)=-3.89, p<.001), Coding (t(44)=2.54, p=.02) and Letter Fluency (t(44)=2.07, p=.05) 
than those not receiving treatment. No significant differences were found between groups in 
depressive severity (both BDI-II and HDRS), functional limitations, and all other demographic 
and cognitive variables. 
 Engagement and minutes trained by concurrent treatment. Results are shown in 
Table 12. Mean training time significantly differed between individuals receiving 
treatment and those who were not (t(44)=-4.14, p=<.001). Participants receiving concurrent 
treatment trained an average of 392 minutes (SD=269) whereas those who were not receiving 
treatment trained an average of 144 minutes (SD=131). There were no significant group 
differences in engagement (t(44) = -.491, p=.62) and attrition rates, (Χ2 (1, N= 46) = 1.75, p=.19). 
One participant receiving concurrent treatment and 10 participants not receiving treatment 
dropped out before the end of the study.   
 
 Effect of concurrent treatment on regressed change scores. Results are shown in 
Tables 13 and 14. The degree of improvement on CVLT Short-Delay Recall was significantly 
greater for participants receiving concurrent treatment than not (β=6.29, t(42)=2.05, p=.04, d=-
.06). Participants receiving concurrent treatment recalled an average of 6.29 more words than 
participants not receiving treatment. The degree of improvement continued to be significantly 
greater for participants receiving concurrent treatment after additionally adjusted for WTAR 
score (β=7.17, t(41)=2.04, p=.04).  No significant group differences in mean change scores were 
found on all other cognitive variables.   
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Hypothesis 3  
 
Results are shown in Table 15. The magnitude of improvement on Inhibition was 
marginally higher for individuals with lower baseline BDI-II scores (β=0.17, t(42)=1.65, p=.10, 
r2=.04). With a one-point increase in baseline BDI-II score, there was a tendency for participants 
to take an additional .17 seconds to complete the task. No significant differences in mean change 
scores were found on all other cognitive variables.  
 
DISCUSSION 
Training Group Comparisons 
This pilot study examined the cognitive benefits of PS/EF-based CCT for young adults 
with mild-to-moderate depressive symptoms compared to an active control of verbal training.  
The first aim of determining whether PS/EF training resulted in greater cognitive improvement 
than the active control was partially met.  PS/EF training resulted in differentially greater 
improvement on several aspects of PS and EF, though improvements in attention and verbal 
learning and memory were comparable between training groups. The second aim of identifying 
whether certain demographic, clinical, and treatment factors differentially impacted CCT 
response was also partially met. A few racial differences in CCT response were observed on 
measures of PS and EF, but concurrent treatment and depressive severity were largely 
unremarkable.    
Our findings of PS/EF training resulting in differentially greater improvements in PS and 
EF (i.e., positive near transfer) were consistent with and contribute to the literature on CCT, 
which, to our knowledge, has primarily focused on older adults (Berry et al., 2010; Borella et al., 
2010; Karbach & Verhaeghen, 2014; Lampit, Hallock, & Valenzuela, 2014; Lohman et al., 2013; 
West et al., 2019), stroke and acquired brain injuries (Bogdanova, Yee, Ho, & Cicerone, 2016; 
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De Luca et al., 2018; Hallock et al., 2016; van de Ven, Murre, Veltman, & Schmand, 2016), and 
individuals with severe mental health illness (Preiss et al., 2013; Talarowska et al., 2015). Fewer 
studies have examined the cognitive effects of CCT in depression (Koster et al., 2017; Motter et 
al., 2016a), and specifically, among younger adults who are known to be most at risk. Our 
findings cannot reflect practice effects alone as both groups were given the same battery twice, 
yet significant differences in improvement were still observed, and because the magnitude of 
improvement was greater than is expected from practice effects alone (Bartels, Wegrzyn, Wiedl, 
Ackermann, & Ehrenreich, 2010; Bornstein, Baker, & Douglass, 1987). Moreover, it can be 
argued that significant transfer to real-life outcomes, such as to mood and functional living, is 
evidence of the effectiveness of the intervention.  
While PS/EF training resulted in differentially larger near effects, the magnitude of 
improvement did not differ between groups on farther measures of cognition (e.g., attention and 
verbal learning/memory). This is in contrast to the prolific ACTIVE (Rebok et al., 2014) and 
IHAMS studies (Wolinsky et al., 2015) that found that PS and EF training were superior in 
producing far transfer effects, though these studies were based on cognitively-healthy, older 
adults who were tracked over five to 10 years, suggesting it may not be generalizable to young 
adults with depression and/or it may take longer than eight weeks to detect change. Differences 
in training protocol may also account for the discrepant findings. First, participants in the 
ACTIVE and IHAMS studies received 600 minutes of training, which research personnel 
ensured by having them complete training in a laboratory setting. However, this introduces the 
threat of social engagement, and thus we had participants complete the training independently 
and did not intervene if they missed a day of training. We instructed participants to train for a 
minimum of 600 minutes, yet both groups fell short of the requirement. The PS/EF group trained 
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for a total of 281 minutes and the verbal group trained for a total of 138 minutes. Greater benefits 
mught have been observed had they adhered to the recommended amount; that said, there is no 
consensus in the literature on the optimal amount of training for maximum therapeutic and 
cognitive benefit. Training times range from 90 minutes (Calkins, McMorran, Siegle, & Otto, 
2015) to over 1000 minutes (Bowie et al., 2013) across successful programs for adults with 
depression. Trials of CCT for schizophrenia (Wykes, Huddy, Cellard, McGurk, & Czobor, 2011) 
and mild cognitive impairment (Sherman, Mauser, Nuno, & Sherzai, 2017) have not found a 
relationship between increased training time and effect size. Second, differences in training 
schedules may account for the discrepanct findings, as the duration of each session, spacing 
between sessions, and total number of sessions have all been shown to affect treatment response, 
with longer and less frequent sessions more effective than shorter and more frequent sessions. 
This is because short but more frequent sessions tend to lead to fatigue, loss of motivation, and 
boredom (Anguera et al., 2012; Holtzer et al., 2010; Persson et al., 2007). Lampit et al. (2014) 
found that sessions that were at least 30 minutes long and administered one to three times per 
week were more effective than shorter sessions that were administered more frequently (four or 
more sessions). The training schedule in the ACTIVE study better accord to these guidelines, as 
participants received ten, 60-75 minutes sessions, two to three week, for six weeks (Rebok et al., 
2014). Greater transfer may have been observed had training been distributed as such; however, 
there is also evidence to suggest that spreading the same amount of training across a longer time 
period is most beneficial (Wang et al., 2014). Lastly, participants in the ACTIVE and IHAMS 
studies trained on a pre-selected set of exercises whereas we gave participants the opportunity to 
select among the five modules that they were assigned. However, Bozoki, Radovanovic, Winn, 
Heeter, & Anthony (2013) found that freedom to select one’s training impeded cognitive 
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improvement because there was a tendency to select games that were relatively easy, thus 
exercising a cognitive skill that likely did not need strengthening or rehabilitating.   
As mentioned, both training groups demonstrated comparable improvement on most 
cognitive and affective measures. This suggests the mechanistic agent in CCT is likely not the 
specific training content, but is rather found in the factors that are common to both training 
conditions. Both groups participated in a novel task that was presented on a similar interface, 
scaled in difficulty, and provided immediate feedback. Both groups were given identical 
instructions and descriptions of the program, as to anticipate the same general improvements in 
cognition. Both groups spent the same amount of time interacting with research personnel at pre- 
and post-testing. Accordingly, the possibility of nonspecific factors partially driving CCT 
response cannot be ruled out – even in the context of comparable levels of engagement on the 
UES.  
 The possibility of nonspecific factors underlying CCT response is consistent with the 
Environmental Enrichment Hypothesis and the Neutrophic Hypothesis of Depression, in that 
both consider the importance of cognitive stimulation in inducing cognitive and neuronal 
plasticity. Any activity that is challenging, novel, and engaging will result in an upregulation of 
BDNF (Rothman & Mattson, 2013), and in the context of depression, potentially in the CNN. 
This may explain why CCT has been found to be as beneficial as other behavioral interventions 
for depression. Sungkarat, Boripuntakul, Kumfu, Lord, & Chattipakorn (2018) found that 
multiple sessions of Tai Chi to a novice group increased plasma BDNF and improved verbal 
memory and cognitive flexibility. Håkansson et al. (2017) found a positive correlation between 
cognitive improvement and BDNF change following physical exercise, cognitive training, and 
mindfulness practice; interestingly, the effect was greatest among those with the lowest levels of 
  51 
 
BDNF at baseline, in support of ceiling effects in BDNF response. Given ceiling effects in 
BDNF upregulation and given that BDNF may underlie cognitive improvement, it is plausible 
that cognitive improvement is also limited by ceiling effects and would thus explain our findings 
of comparable improvement between training groups. Future research may consider 
incorporating blood work in order to evaluate the relationships among cognitive training, BDNF, 
and cognitive improvement. Along the line of ceiling effects, our relatively high-functioning 
sample may not have been an appropriate sample, as their baseline performance on 
neuropsychological measures fell within normal limits. While their baseline performance may 
reflect a decline from premorbid levels, it difficult to ascertain in the absence of norms that 
additionally match for years of education. It is possible that individuals with greater functional 
impairment or more severe depressive symptomology may stand to benefit, yet this is not 
supported by our analyses. Additionally, the significant overlap in training content may explain 
the comparable improvement between groups. The verbal modules were timed to equate to the 
PS/EF modules in duration (i.e., to control for training amount), thereby providing the active 
control group with some degree of PS training as well. The verbal modules also required a 
minimal degree of attentional processing, decision making, and motor control, thereby 
necessitating the use of EF. We cannot rule out task impurity in this study, but it is questionable 
whether this can be accomplished at all in CCT.  
 
Predictors of CCT Response 
Race 
 Contrary to expectations, Whites demonstrated significantly greater improvement than 
Asians on measures of EF (letter fluency and rapid set-shifting) and trended towards greater 
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improvement on measures of PS (Coding and Combined Color Naming and Word Reading). 
These differences were likely undue to engagement, as scores on the UES, total training time, 
and attrition rates were comparable between groups. Baseline videogame playing frequency did 
not significantly differ between groups either, suggesting it is unlikely due to potential ceiling 
effects of CCT. It is noteworthy that the majority of our Asian participants were recruited from 
the surrounding areas of a university known for its large and diverse Asian immigrant 
population. It is possible they spoke another language and/or acquired English proficiency at a 
later time. Research shows that knowing another language, while largely beneficial and 
neuroprotective (Marian & Shook, 2012), comes at the cost of slower word automaticity and 
retrieval due to reduced vocabulary in each language (fewer opportunities to practice) and 
greater demands on cognitive control to select the correct response in the correct language  
(Bialystok, 2009), which, in turn, may explain why Asians scored significantly lower on a 
vocabulary measure (WTAR). We screened for English proficiency, but we did not 
systematically assess age of English acquisition or other languages spoken. However, it is 
unlikely that bi/multilingualism fully accounts for the results as the degree of improvement 
remained statistically significant when adjusted for WTAR and there were no baseline 
differences on any other cognitive measure. It is noteworthy that Asians endorsed significantly 
fewer depressive symptoms than Whites on a self-reported measure, but they did not differ on an 
examiner-rated measure of depression. This disparity was consistent with the literature of Asians 
underreporting the extent of their emotional distress and to experience their emotional distress 
somatically (Kim, Park, Storr, Tran, & Juon, 2015; Novick et al., 2013; Yeung, Chang, Gresham 
Jr, Nierenberg, & Fava, 2004) than their White counterparts. Several explanations have been 
proposed for the differential reportings (Leong & Lau, 2001; Novick et al., 2013), but what is 
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clear from the CR literature is that conscious awareness and insight into one’s difficulties and 
symptoms are  for optimal treatment response. Indeed, the first step in most treatment protocols 
for individuals with TBI (Goverover, Johnston, Toglia, & DeLuca, 2007; Schmidt, Fleming, 
Ownsworth, Lannin, & Khan, 2012), stroke (Leung & Liu, 2011), and substance abuse (Castine 
et al., 2019; Goldstein et al., 2009) is to increase awareness of their cognitive and emotional 
symptoms and it is therefore not inconceivable for the same to be true in depression.  
Alternatively, factors that have historically impacted lower treatment response in Asians may 
have been at play in the current study, such as mistrust toward the medical system (and research 
institutions) and differences in communication between research team and participant (George, 
Duran, & Norris, 2014; Leong & Lau, 2001; Noël & Whaley, 2012). Further research is 
recommended to eludiate the factors that contribute to differential rates of cognitive 
improvement from computerized cognitive training.  
 
Concurrent treatment  
Concurrent treatment did not enhance CCT response in our analyses, contrary to the gold 
standard of combined medication and psychotherapy for depression (Malhi et al., 2015); yet, the 
gold standard is typically in relation to the affective symptoms and less, if at all, to the cognitive 
symptoms. This study’s findings were inconsistent with those that found that adding CCT to 
medication or physical activity was superior in improving cognition in depression than CCT 
alone (Joubert & Chainay, 2018; Zhu, Yin, Lang, He, & Li, 2016), though consistent with others 
(Desjardins-Crépeau et al., 2016; Moshier & Otto, 2017; Rahe et al., 2015b). Several 
explanations are provided to potentially account for the inconsistency in findings. First, the 
current study was underpowered, as only eleven participants were receiving concurrent treatment 
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in our sample. Second, the study did not assess the specific type of psychotherapy (e.g., CBT, 
Interpersonal, Behavioral) or pharmacological treatment, which are known to have differential 
neurocognitive effects. Citalopram has been shown be more effective than other SSRIs in 
ameliorating cognitive symptoms (Biringer, Rongve, & Lund, 2009) and psychoeducation has 
been shown to be most effective in ameliorating the cognitive symptoms in young adults 
(Morey-Nase et al., 2019). Third, adherence to treatment was not assessed, which is particularly 
problematic, as young adults have a higher rate of non-compliance or partial compliance than all 
other age groups (Rolnick, Pawloski, Hedblom, Asche, & Bruzek, 2013). Fourth, the length of 
the primary treatment was not assessed, which is crucial, as psychotherapy and medication take 
at least 4 weeks to take effect (Montgomery, 1997). Fifth, there were several significant baseline 
differences between groups which may have reflected a selection bias for pursuing mental health 
treatment and/or were the consequences of the primary treatment itself; however, due to low 
power, this was not adjusted for in the present study. Sixth, several studies have shown the lower 
initial BDNF levels (Rahe et al., 2015a) and lower education level (Kalbe et al., 2018) predicts 
response to combined treatment with a CCT component, in support of the Compensation Effect 
(Lövdén, Brehmer, Li, & Lindenberger, 2012). Our relatively high-functioning, college-educated 
sample may have been inappropriate in assessing the superiority of combined treatment versus 
CCT alone.  
While concurrent treatment did not enhance most cognitive outcomes, there was one 
exception: verbal immediate memory. Individuals receiving concurrent treatment evidenced 
significantly greater improvement than individuals not receiving treatment. This finding accords 
with the understanding of memory functioning as a state marker of depression that can be 
ameliorated with proper treatment. Research has consistently demonstrated the independent 
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benefits of antidepressant medication (Culang‐Reinlieb, Sneed, Keilp, & Roose, 2012; Prado, 
Watt, & Crowe, 2018) and psychotherapy (Docteur, Mirabel-Sarron, Guelfi, Rouillon, & 
Gorwood, 2013; Ferguson et al., 2016) on memory. That said, improvements in verbal memory 
likely reflect the synergic benefits of combined treatment than the primary treatment alone, as we 
adjusted for baseline scores and used change scores in our analyses. Indeed, there is emerging 
evidence that each modality of a comprehensive antidepressant regime plays a unique and vital 
role in restoring the hippocampal network in depression. Specifically, whereas medication and 
physical activity induces neurogenesis within the dentate gyrus, CCT integrates and strengthens 
the connections within the hippocampal network (Olson, Eadie, Ernst, & Christie, 2006). Heisz 
et al. (2017) found that combined physical exercise and cognitive training resulted in greater 
memory recall and up-regulation of neurotropic factors (serum BDNF and insulin-like drown 
factor-1) than each modality alone, yet groups did not differ in memory recognition, which 
suggests that the benefits of combined training are limited to the hippocampal regions and 
minimally extend to higher-order, prefrontal regions. It is noteworthy that our findings contradict 
those from Motter et al. (2016a), in which verbal memory did not improve; however, there was 
significant heterogeneity across studies and were based on older samples.  
 
Depressive severity  
Depressive severity did not significantly affect CCT response, consistent with the 
literature on CCT, including the hallmark IHAMS study (Lohman et al., 2013; Wolinsky et al., 
2015), as well as the literature on other treatment modalities for depression (Furukawa et al., 
2018; Furukawa et al., 2017; Rabinowitz et al., 2016). A thorough meta-analysis by Weitz et al. 
(2015) found that baseline depressive severity, whether self-reported or clinician-rated, did not 
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impact treatment response to antidepressants and CBT. This, however, contrasts with other 
findings of individuals with severe depression beneftting more from antidepressants (Fournier et 
al., 2010; Schmitt et al., 2009), psychological treatments (Bower et al., 2013; Driessen, Cuijpers, 
Hollon, & Dekker, 2010), and transcranial magnetic stimulation (Ferrucci et al., 2009). A meta-
analysis by Fournier et al. (2010) found response to antidepressant medication was comparable 
between patients with mild and moderate depression, yet significantly greater for severe 
depression (HAMD ≥ 25). Given our sample’s relatively mild depressive symptoms, with a large 
minority (35%) failing to meet diagnostic criteria for MDD, the question remains whether CCT 
is most effective for severe depression, as found by Semkovska and Ahern (2017). Alternatively, 
the findings may be explained by measurement issues related to depression rating scales. Several 
meta-analyses have concluded that depression ratings scales are not equally sensitive in detecting 
change (i.e., treatment response) across the depression severity spectrum. Isacsson and Adler 
(2012) found depression rating scales “systematically underestimate” improvement at lower 
baseline levels of depression more than at higher levels, thereby making them less precise and 
prone to the risk of type II error. Our analyses may have been subject to such bias; that said, 
most of the criticism has been on clinician-rated scales (Schneibel et al., 2012), such as the 
HDRS or the Montgomery–Asberg Depression Rating Scale, which is among the reasons the 
BDI-II was selected as the independent variable, though the BDI-II is not without exception 
(Wang & Gorenstein, 2013). Additionally, other indicators of depression severity may be more 
predictive of CCT response, as is the case for other depression treatments, such as shorter 
duration of current episodes and fewer total episodes (Shilyansky et al., 2016; Sotsky et al., 
2006), transcranial magnetic stimulation (Holtzheimer III, Russo, Claypoole, Roy‐Byrne, & 
Avery, 2004), and depression subtype. There is evidence that individuals with melancholic-, 
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atypical-, anxious-, and double- depression respond differently to standard antidepressant 
treatment, even when adjusting for baseline severity (Fava et al., 1997). To the present 
researcher’s knowledge, no study has examined these depression indictors or depression 
subtypes in CCT response, suggesting a promising new avenue of research.  
 
Study Strengths 
The current study has several unique strengths. First, it was a double-blind, randomized 
study designed to understand the mechanism of CCT in depression. The inclusion of an active 
control improves upon the methodological flaws in previous studies, which mostly relied on 
waitlist or passive control conditions (Bowie et al., 2013; Elgamal, McKinnon, Ramakrishnan, 
Joffe, & MacQueen, 2007; Marı, Sotres, León, Estrella, & Sosa, 2008; Naismith et al., 2011; 
Oertel-Knöchel et al., 2014; Siegle et al., 2014). While such control conditions account for 
practice effects, they are inadequate in controlling for other threats, such as statistical regression 
to the mean, systematic selection biases, and non-specific effects (Boot et al., 2013; Simons et 
al., 2016). To address these threats, the active control in the present study was matched with the 
intervention group in expectancy, engagement, motivation, and novelty (e.g., both were 
presented on the same user face, scaled in difficulty, and provided immediate feedback). Both 
groups received the same number of training modules (varying only in content) and were 
instructed to train for a total minimum of 600 minutes. Both groups had limited contact with the 
research team, thereby controlling for the threat of social engagement. Second, the modality 
through which the intervention was administered has been scantly explored in the literature 
(Tacchino et al., 2015; Vergani & Marton, 2019). In the present study, participants downloaded a 
phone application and trained on their mobile phones independently, which is more accessible, 
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convenient, and empirically-rigorous than supervised training sessions in a laboratory that have 
been commonly used in most previous studies (Lohman et al., 2013; Rebok et al., 2014). Third, 
to our knowledge, this is the first study on CCT that used multiple imputations for missing data 
instead of more conventional methodologies, such as listwise deletion (dropping cases with 
missing data and only analyzing those with complete data), thereby representing an analytical 
innovation in the field and stregnthens statistical rigor by reducing estimate bias and preserving 
statistical power (use citation from above in meth section). Multiple Imputation assumes that 
there is no relationship between the missingness of data on any observed or unobserved value 
(missing completely at random, MCAR) or that there may be a systematic relationship between 
the missing data and the observed data, but not the missing data (missing at random, MAR). It is 
nearly impossible to check for MCAR or MAR (Childress, 2019; Grace-Martin, 2019), as by 
definition, one cannot compare the unobservable characteristics, which is where the problem 
may lie (if it exists). Consequently, the best one can do is to compare the observable 
characteristics. Descriptive statistics were calculated for all observable pre-treatment 
characteristics of completers and non-completers of the study (21 characteristics). Seventeen 
showed no statistical difference. Three were significant at the 5% level. This does not imply that 
completers and non-completers were significantly different, as by assumption of hypothesis 
testing, one will wrongly reject the true null a certain percentage of times (Editor, 2015). Thus, 
the descriptive statistics indicate no consistent differences between completers and non-
completer, which justifies the use of multiple imputation. Fourth, we evaluated the role of other 
factors (besides content) that impact CCT response, which has been often advocated in the 
literature (Boot & Kramer, 2014; Jaeggi et al., 2014) and in line with the goal of personalized 
treatment. Fifth, we used multiple tests to assess each cognitive domain to more accurately 
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determine whether CCT improves underlying cognitive abilities or task-specific gains on a single 
test (Green & Bavelier, 2015; Noack et al., 2014). Sixth, most CCT trials for depression are 
based on older samples (Lohman et al., 2013; Morimoto et al., 2014; Naismith et al., 2011), with 
less attention given to younger adults, who have the highest prevalence rate of depression of all 
age groups (Hasin et al., 2018) and which is associated with significant morbidity and mortality 
(Breslau et al., 2008; Bruffaerts et al., 2015; Cuijpers et al., 2013; Lerner & Henke, 2008). 
Lastly, most CCT trials on depression focused primarily on ameliorating mood symptoms 
(Calkins et al., 2015; Segrave, Arnold, Hoy, & Fitzgerald, 2014; Wolinsky et al., 2009c), with 
less attention on its associated cognitive symptoms, which are known to precede and persist 
beyond the resolution of affective symptoms (Ahern & Semkovska, 2017; Herrera-Guzmán et 
al., 2010; Lee et al., 2012), increase the risk of relapse and recurrence (Fossati et al., 2002), and 
interfere with full recovery of MDD (Bortolato et al., 2016). 
 
Study Limitations and Future Directions 
The current study has several limitations that warrant attention. First, the study did not 
include a waitlist control group. Given that previous studies have already shown the superiority 
of CCT to a waitlist control, this study was designed to determine whether the specific content of 
CCT produced differentially larger effects. Nonetheless, the lack of a waitlist control group 
raises the possibility that the observed effects are attributable to the passage of time and the 
cyclical nature of mood in depression. Indeed, the rate of spontaneous remission from MDD is as 
high as 23% (Whiteford et al., 2013). That said, these time effects are typically related to the 
affective symptoms of MDD and less to the cognitive symptoms of MDD, which are known to 
be more persistent (Douglas & Porter, 2009; Talarowska et al., 2015; Weiland-Fiedler et al., 
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2004). Thus, it is unlikely cognitive improvement occurred spontaneously within the 8-week 
study period.  
The lack of a waitlist control group also raises the question of practice effects; that is, 
whether the gains observed represent the benefits of the intervention or from familiarity with the 
tests that comes with repeated testing (Goldberg, Harvey, Wesnes, Snyder, & Schneider, 2015). 
Performance on PS tests are particularly susceptible to practice effects, as familiarity results in 
greater neuronal efficiency and faster response time (Estevis, Basso, & Combs, 2012; Salthouse, 
2000). However, as mentioned above, the magnitude of improvement was greater than expected 
from practice effects alone (Bartels et al., 2010; Bornstein et al., 1987; Falleti, Maruff, Collie, & 
Darby, 2006) and transfer to real-life outcomes may serve as evidence of true effects. Second, 
the study relied on a convenience sample of young adults with mild-to-moderate depressive 
symptoms, which is not the same as a diagnosis of MDD. Our findings may therefore not 
generalize to individuals with more severe MDD and across different patient statuses (e.g., 
inpatient vs. outpatient). Nonetheless, 65% of our sample met diagnostic criteria for MDD and 
we did not find that depressive severity significantly impacted CCT response. Third, there was a 
significant overlap in training content between the two groups, such that the control condition 
contained some degree of PS training. Fourth, face validity was used to select the modules for 
the study so it possible that each group did not train in their respective domain. Lastly, our test 
battery did not reflect the full range of EF subdomains, such as abstract reasoning, planning, and 
problem-solving. We focused on the subdomains that are commonly affected in MDD (e.g., 
inhibition, cognitive flexibility, and letter fluency), which we recognize overlaps with some of 
the content of the EF/PS modules, and therefore it remains unclear whether CCT is limited to 
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near transfer.  Future studies may consider assessing these subdomain to better understand the 
benefits of transfer to untrained domains.  
 
CONCLUSION 
This was a double-blind, randomized pilot study designed to evaluate the mechanism of 
action of CCT in depression. Forty-six young adults with mild-to-moderate depressive severity 
were randomized into a PS/EF training group or an active condition group of non-fluency-based 
verbal training. After 8 weeks of training, PS/EF resulted in differentially larger near transfer 
effects but was comparably effective as the active control on measures of far transfer. Race, 
concurrent treatment, and depressive severity did not significantly impact CCT response. In all, 
the findings suggest that the mechanism agent in CCT is likely not driven by the specific training 
content, but rather, on the factors common to both training conditions. The role of non-specific 
factors cannot be ruled out, as both groups were exposed to a novel, challenging, and engaging 
activity.  
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Table 1  
Inclusion and exclusion criteria  
Inclusion Criteria 
1. Individuals ages 18-29 (inclusive) at the time of informed consent 
2. English proficiency as determined per conversational discourse and clinical evaluation 
3. HDRS ≥ 10 
4. Daily access to a smartphone or tablet with internet connection for the study duration 
5. Willing and able to complete mood and neuropsychological testing 
6. IQ ≥ 85 as determined by the Wechsler Test of Adult Reading  
Exclusion Criteria 
1. Lack of English proficiency  
2. Active suicidal intent at time of screening  
3. Past or current major psychiatric condition (schizophrenia, schizoaffective disorder, 
psychosis, or bipolar I/II disorder), neurological condition (seizures/epilepsy, multiple 
sclerosis, traumatic brain injury, stroke), thyroid disease, cancer, or HIV/AIDS 
4. Regular online brain games (e.g., Luminosity, Brain HQ, Happy Neuron) or non-fluency 
verbal games (crossword puzzles), as defined by engaging in this activity ≥ 2 times per 
week in the past year  
5. Illicit drug use (cocaine, heroin, amphetamines, barbiturates, hallucinogens, inhalants) or 
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Table 2 
Baseline characteristics of completer versus noncompleter  
 Non-Completers Completers 
(n=11) (n=35) 
  M or %  SD or n M or %  SD or n t or X2 p 
Age at evaluation 21.64 2.50 20.74 3.99 t = 0.70 .489 
Sex          X2 = 0.47 .494 
Male 36.36% 4 25.71% 9     
Female 63.36% 7 74.28% 26     
Highest educational attainment 14.64 1.12 14 2.09 t = 0.95 .340 
Race/ethnicity          X2 = 2.51 .642 
White 45.50% 5 45.70% 16     
Black 0.00% 0 5.70% 2     
Hispanic 18.20% 2 11.40% 4     
Asian  36.40% 4 25.70% 9     
Other  0.00% 0 11.40% 4     
Frequency playing video 
games per week 
        X2 = 2.33 .507 
0 hours 45.50% 5 34.30% 12     
1-2 hours 9.10% 1 28.60% 10     
3-4 hours 18.20% 2 8.60% 3     
5+ hours 27.30% 3 28.60% 10     
Currently taking medication 
for depressive symptoms 
        X2 = 0.69 .405 
No  90.90% 10 80.00% 28     
Yes 9.10% 1 20.00% 7     
Currently in psychotherapy for 
depressive symptoms 
        X2 = 0.20 .655 
No 90.90% 10 85.70% 30     
Yes 9.10% 1 14.30% 5     
Hamilton Depression Rating 
Scale 
15.91 7.79 16.38 4.75 t = -0.24 .809 
BDI-II 21.55 13.55 23.41 11.07 t = -0.46 .646 
Sheehan Disability Scale  12.64 7.51 15.97 6.28 t = -1.47 .150 
WTAR 37.4 7.66 39.26 8.38 t = -0.63 .533 
WAIS Coding  69.3 8.96 78.69 15.82 t = -1.79 .081 
DKEFS Combined Color 
Naming & Word Reading   
10.4 2.01 11.17 2.19 t = -1.00 .323 
DKEFS Number Sequencing  29.6 7.09 28.6 10.11 t = 0.23 .772 
DKEFS Letter Fluency  30.55 11.4 29.14 9.7 t = 0.40 .690 
DKEFS Number-Letter 
Sequencing  
84.2 36.57 63.82 20.23 t = 2.31 .026 
DKEFS Inhibition 50.9 11.61 45.62 10.38 t = 1.38 .174 
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WAIS Digit Span Forward  10.91 1.97 10.91 2.02 t = -0.01 .994 
CVLT Total Learning  50.64 9.75 57.2 7.64 t = -2.33 .025 
CVLT Short Delay Free Recall  10.55 3.30 12.51 2.34 t = -2.20 .033 
CVLT Long Delay Free Recall  11.36 2.77 12.57 2.13 t = -1.53 .135 
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Table 3 
Baseline characteristics of CCT groups  
  
Overall Sample Verbal PS/EF 
    
(n=46) (n=21) (n=25) 
  M or %  SD or n M or %  SD or n M or %  SD or n  t or X2 p 
Age at evaluation 21.0 3.7 21.7 4.5 20.3 2.8 t = 1.29 .204 
Sex              X2 = 0.002 .966 
Male 28.3% 13 28.6% 6 28.0% 7     
Female 71.7% 33 71.4% 15 72.0% 18     
Highest educational 
attainment 
14.2 1.9 14.5 2.23 13.8 1.6 t = 1.22 .230 
Race/ethnicity              X2  = 6.78 .148 
White 45.7% 21 33.3% 7 56.0% 14     
Black 4.2% 2 4.8% 1 4.0% 1     
Asian  28.3% 13 33.3% 7 24.0% 6     
Hispanic  13.0% 6 9.5% 2 16.0% 4     
Other  8.7% 4 19.0% 4 0.0% 0     
Frequency playing video 
games per week 
            X2  = 1.91 .592 
0 hours 37.0% 17 33.3% 7 40.0% 10     
1-2 hours 23.9% 11 33.3% 7 16.0% 4     
3-4 hours 10.9% 5 9.5% 2 12.0% 3     
5+ hours 28.3% 13 23.8% 5 32.0% 8     
Currently taking medication 
for depressive symptoms 
            X2 = 1.11 .293 
No  82.6% 38 76.2% 16 88.0% 22     
Yes 17.4% 8 23.8% 5 12.0% 3     
Currently in psychotherapy 
for depressive symptoms 
            X2 = 0.42 .516 
No 87.0% 40 90.5% 19 84.0% 21     
Yes 13.1% 6 9.5% 2 16.0% 4     
Hamilton Depression Rating 
Scale 
16.3 5.54 17.2 6.2 15.4 4.9 t = 1.10 .277 
BDI-II 23.0 11.6 26.4 13.2 20.1 9.3 t = 1.91 .062 
Sheehan Disability Scale  15.2 6.7 18.4 7.0 12.4 5.0 t = 3.37 .002 
WTAR 38.8 8.2 39.7 6.8 38.1 9.3 t = 0.63 .534 
  110 13.8 111 11.2 109 15.9     
WAIS Coding  76.6 15.0 74.9 13.0 78.0 16.6 t = -0.70 .491 
  10.8 2.8 10.5 2.3 11.1 3.1     
DKEFS Combined Color 
Naming & Word Reading   
12 2.2 12.0 2.0 12.0 2.3 t = 0.19 .939 
  11.0 2.2 11.0 2.0 11.0 2.3     
DKEFS Number 
Sequencing  
28.8 9.5 30.0 9.6 27.8 9.5 t = 0.75 .460 
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  10.3 2.6 9.9 2.5 10.6 2.6     
DKEFS Letter Fluency  38.9 10.7 38.0 10.4 39.8 11.1 t = -0.57 .571 
  11.1 3.2 10.7 3.0 11.4 3.4     
DKEFS Number-Letter 
Sequencing  
68.3 25.8 69.1 23.5 67.7 28.1 t = 0.19 .848 
  9.9 2.8 9.9 2.7 9.9 3.0     
DKEFS Inhibition 46.8 10.8 47.7 10.4 46.0 11.2 t = 0 .51 .595 
  10.9 2.6 10.8 2.5 11.1 2.8     
WAIS Digit Span Forward  10.9 2.0 11.2 2.0 10.6 2.0 t = 1.02 .315 
  10.4 2.7 10.8 2.6 10.0 2.7     
CVLT Total Learning  55.6 8.6 56.5 7.8 54.9 9.2 t = 0.61 .545 
  10.7 2.9 11.1 2.8 10.3 2.9     
CVLT Short Delay Free 
Recall  
12.0 2.7 11.9 2.5 12.2 2.9 t = -0.32 .753 
  10.3 2.9 10.1 2.9 10.6 3.0     
CVLT Long Delay Free 
Recall  
12.3 2.3 12.5 2.3 12.1 2.4 t = 0.51 .610 
  10.0 2.4 10.0 2.5 9.8 2.3     
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Table 4 
Engagement and minutes trained by CCT group   





 M SD M SD t or U p 
Total minutes trained 281 266 138 85.9 U = 197.5 .152 
UES Total 91.8 9.39 91.0 12.3 t = 0.24 .811 
Focused Attention 3.29 0.64 3.26 0.78 t = 0.11 .909 
Perceived usability 2.43 0.71 2.65 0.82 t = -0.91 .362 
Aesthetics 4.31 0.50 4.12 0.55 t = 1.12 .265 
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Table 5 
Effect of CCT group on regressed change scores of individual tests, covarying for respective 
baseline score 
          95% CI   






 Hamilton Depression Rating Scale Difference 
Intercept -6.78 0.92 -7.35 <.001 -8.6 -4.97   
Group -1.04 1.19 -0.87 .39 -3.38 1.30 -.071 
Baseline HDRS -0.83 0.12 -7.23 <.001 -1.06 -0.61  
 BDI-II Difference 
Intercept -8.92 1.76 -5.08 <.001 -12.38 -5.47   
Group -2.26 2.33 -0.97 .33 -6.84 2.32 -.208 
Baseline BDI-II -0.71 0.11 -6.76 <.001 -0.92 -0.51  
 Sheehan Disability Scale Difference 
Intercept -4.78 1.33 -3.58 <.001 -7.39 -2.16   
Group -0.81 1.94 -0.42 .68 -4.62 3.00 -.427 
Baseline Sheehan -0.61 0.15 -4.12 <.001 -0.90 -0.32  
 Coding Difference 
Intercept 6.45 2.09 3.09 <.001 2.35 10.55   
Group 6.70 2.83 2.37 .02 1.15 12.25 -.449 
Baseline Coding -0.50 0.10 -5.17 <.001 -0.69 -0.31  
 Combined Color Naming & Word Reading Difference 
Intercept -0.02 0.41 -0.04 .97 -0.82 0.79   
Group 0.24 0.49 0.49 .63 -0.72 1.19 -.118 
Baseline CNR -0.52 0.12 -4.56 <.001 -0.75 -0.30  
 Number Sequencing Difference 
Intercept -5.69 0.97 -5.86 <.001 -7.60 -3.78   
Group -1.26 1.29 -0.98 .33 -3.78 1.27 .011 
Baseline Number 
Sequencing 
-0.55 0.07 -8.03 <.001 -0.68 -0.42  
 Letter Fluency Difference 
Intercept 7.28 2.07 3.53 <.001 3.23 11.33   
Group 2.14 2.81 0.76 .45 -3.38 7.66 -.128 
Baseline Letter Fluency -0.45 0.13 -3.40 <.001 -0.72 -0.19  
 Number-Letter Sequencing Difference 
Intercept -10.36 2.39 -4.34 <.001 -15.04 -5.68   
Group -10.02 3.29 -3.04 <.001 -16.48 -3.56 .405 
Baseline Number-Letter -0.75 0.07 -11.20 <.001 -0.88 -0.62  
 Inhibition Difference 
Intercept -2.79 1.79 -1.56 .12 -6.32 0.73   
Group -3.93 2.34 -1.68 .09 -8.53 0.66 .367 
Baseline Inhibition -0.42 0.11 -3.82 <.001 -0.63 -0.20   
  Digit Span Forward Difference 







Intercept 0.21 0.54 0.39 .69 -0.85 1.27   
Group -0.06 0.76 -0.07 .94 -1.55 1.44 -.111 
Baseline Digit Span 
Forward 
-0.58 0.18 -3.19 <.001 -0.94 -0.23   
  CVLT Total Learning Difference 
Intercept 4.14 1.61 2.57 .01 0.98 7.30   
Group 1.16 2.18 0.53 .59 -3.11 5.43 -.238 
Baseline Total Learning -.53 .14 -3.92 <.001 -.80 -.26   
  CVLT Short Delay Free Recall Difference 
Intercept 4.27 1.98 2.16 .03 .40 8.15   
Group -2.53 2.65 -0.95 .34 -7.71 2.66 .292 
Baseline Short Delay -1.12 0.51 -2.22 .03 -2.11 -.13   
  CVLT Long Delay Free Recall Difference 
Intercept 1.09 .42 2.62 .01 .27 1.91   
Group .56 .56 1.00 .32 -.54 1.65 -.336 
Baseline Long Delay -.68 .13 -5.34 <.001 -.93 -.43   




Effect of CCT group on regressed change scores of individual tests, covarying for respective 
baseline score and baseline functional limitations 
     95% CI 
  β SE  t  p Lower Bound Upper Bound 
 HDRS Difference 
Intercept -7.17 1.01 -7.07 <.001 -9.18 -5.16 
Group -0.32 1.37 -0.24 .81 -3.02 2.38 
Baseline HDRS -0.92 0.13 -6.89 <.001 -1.18 -0.66 
Baseline Sheehan 0.15 0.13 1.16 .25 -0.10 0.40 
 BDI-II Difference 
Intercept -9.12 1.88 -4.87 <.001 -12.81 -5.43 
Group -1.89 2.58 -0.73 .46 -6.96 3.17 
Baseline BDI-II -0.76 0.15 -4.93 <.001 -1.06 -0.46 
Baseline Sheehan 0.11 0.29 0.36 .72 -0.47 0.68 
 Sheehan Disability Scale Difference 
Intercept -4.78 1.33 -3.58 <.001 -7.39 -2.16 
Group -0.81 1.94 -0.42 .68 -4.62 3.00 
Baseline Sheehan -0.61 0.15 -4.12 <.001 -0.90 -0.32 
 Coding Difference  
Intercept 5.75 2.25 2.55 .01 1.33 10.16 
Group 8.00 3.18 2.52 .01 1.77 14.23 
Baseline Coding -0.50 0.10 -5.13 <.001 -0.69 -0.31 
Baseline Sheehan 0.22 0.24 0.89 .37 -0.26 0.70 
 Combined Color Naming & Word Reading Difference 
Intercept -0.04 0.46 -0.09 .93 -0.97 0.89 
Group 0.29 0.60 0.48 .63 -0.92 1.50 
Baseline CNR -0.52 0.12 -4.31 <.001 -0.76 -0.28 
Baseline Sheehan 0.01 0.06 0.16 .87 -0.11 0.12 
 Number Sequencing Difference 
Intercept -5.61 1.07 -5.26 <.001 -7.72 -3.51 
Group -1.40 1.46 -0.96 .34 -4.28 1.48 
Baseline Number 
Sequencing 
-0.55 0.07 -7.83 <.001 -0.68 -0.41 
Baseline Sheehan -0.02 0.12 -0.21 .83 -0.25 0.20 
 Letter Fluency Difference 
Intercept 7.46 2.26 3.31 <.001 3.04 11.88 
Group 1.81 3.22 0.56 .57 -4.50 8.13 
Baseline Letter 
Fluency 
-0.45 0.14 -3.37 <.001 -0.72 -0.19 
Baseline Sheehan -0.05 0.25 -0.22 .83 -0.55 0.44 
 Number – Letter Sequencing Difference 
Intercept -11.00 2.57 -4.29 <.001 -16.03 -5.97 
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Group -8.85 3.65 -2.43 .02 -16.00 -1.71 
Baseline Number-
Letter 
-0.76 0.07 -11.02 <.001 -0.90 -0.62 
Baseline Sheehan 0.20 0.29 0.68 .50 -0.37 0.77 
 Inhibition Difference 
Intercept -3.76 1.87 -2.01 .05 -7.44 -0.09 
Group -2.15 2.57 -0.84 .40 -7.20 2.89 
Baseline Inhibition -0.40 0.11 -3.75 .00 -0.61 -0.19 
Baseline Sheehan 0.29 0.19 1.53 .13 -0.08 0.67 
 Digit Span Forward Difference 
Intercept 0.48 0.58 0.83 .41 -0.65 1.61 
Group -0.54 0.85 -0.64 .53 -2.23 1.14 
Baseline DSF -0.62 0.18 -3.37 <.001 -0.98 -0.26 
Baseline Sheehan -0.08 0.06 -1.27 .21 -0.20 0.04 
 CVLT Total Learning Difference 
Intercept 4.59 1.75 2.63 .01 1.16 8.02 
Group 0.33 2.46 0.13 .89 -4.49 5.15 
Baseline Total 
Learning 
-0.52 0.14 -3.79 <.001 -0.78 -0.25 
Baseline Sheehan -0.14 0.19 -0.75 .45 -0.52 0.23 
 CVLT Short Delay Free Recall Difference 
Intercept 3.34 2.14 1.56 .12 -0.86 7.53 
Group -0.81 2.99 -0.27 .79 -6.68 5.07 
Baseline Short Delay -1.15 0.50 -2.30 .02 -2.13 -0.17 
Baseline Sheehan 0.29 0.23 1.25 .21 -0.16 0.73 
 CVLT Long Delay Recall Difference 
Intercept 1.22 0.45 2.72 .01 0.34 2.09 
Group 0.32 0.64 0.51 .61 -0.93 1.57 
Baseline Long Delay -0.67 0.13 -5.30 <.001 -0.93 -0.42 
Baseline Sheehan -0.04 0.05 -0.77 .44 -0.14 0.06 
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Table 7 
Baseline characteristics by race  
  
Whites Asian     
(n=21) (n=13)     
  M or %  SD or n M or %  SD or n t or X2 p 
Age at evaluation 21.9 4.76 19.62 1.8 t = 1.65 .108 
Sex          X2 =  0.83 .362 
Male 23.80% 5 38.50% 5     
Female 76.20% 16 61.50% 8     
Years of completed education 14.14 1.71 13.62 1.45 t = 0.924 .362 
Frequency playing video games per 
week 
        X2  = 0.346  .951 
0 hours 47.60% 10 38.50% 5     
1-2 hours 19.00% 4 23.10% 3     
3-4 hours 4.80% 1 7.70% 1     
5+ hours 28.60% 6 30.80% 4     
Currently taking medication for 
depressive symptoms 
        X2  = 1.435 .231 
No  76.20% 16 92.30% 12     
Yes  23.80% 5 7.70% 1     
Currently in psychotherapy for 
depressive symptoms 
        X2  = 2.806 .094 
No  81.00% 17 100% 13     
Yes 19.00% 4 0% 0%     
Hamilton Depression Rating Scale 17.76 6.9 14.17 3.81 t = 1.66 .107 
BDI-II 27.24 11.91 15.69 5.57 t = 3.27 .003 
Sheehan Disability Scale  16.14 6.82 13.69 5.78 t = 1.08 .290 
WTAR 41.33 6.81 33.5 9.41 t = 2.76 .010 
WAIS Coding  74.38 17.67 76.17 13.62 t = -0.30 .765 
DKEFS Combined Color Naming & 
Word Reading 
10.95 2.27 10.33 2.31 t = 0.75 .459 
DKEFS Number Sequencing  29.1 8.25 32.33 11.69 t = -0.93 .359 
DKEFS Letter Fluency  41.71 12.09 37.23 8.51 t = 1.17 .252 
DKEFS Number-Letter Sequencing  68.04 28.91 69.57 23.46 t = -0.16 .877 
DKEFS Inhibition  46.76 12.31 52.72 8.25 t = -1.49 .146 
WAIS Digit Span Forward  11.67 1.98 9.69 1.89 t = 2.87 .007 
CVLT Total Learning Trials  56.38 9.72 54.54 7.87 t = 0.58 .569 
CVLT Short Delay Free Recall  11.71 3.05 12.46 1.66 t = -0.81 .425 
CVLT Long Delay Free Recall  12 2.57 12.08 1.61 t = -0.10 .924 
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Table 8 
Engagement and minutes trained by race  





 M SD M SD t p 
Total minutes trained 228.14 225.89 175.96 221.60 0.659 .514 
UES Total 93.65 13.19 88.33 15.38 0.923 .365 
Focused attention 3.36 0.69 3.39 0.73 -0.099 .922 
Perceived usability 2.71 0.73 2.35 0.83 1.163 .256 
Aesthetics 4.26 0.52 3.94 0.55 1.287 .214 
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Table 9 
Effect of race on regressed change scores of individual tests, covarying for respective baseline 
score  
     95% CI  






 HDRS Difference 
Intercept -8.176 .958 -8.531 <.001 -10.055 -6.298  
Race .765 1.590 .482 .630 -2.351 3.882 -.789 
Baseline HDRS -.773 .132 -5.841 <.001 -1.032 -.513  
 BDI-II Difference 
Intercept -10.919 1.939 -5.630 <.001 -14.720 -7.117  
Race 1.662 3.436 .484 .628 -5.072 8.397 -1.333 
Baseline BDI-II -.704 .150 -4.682 <.001 -.999 -.409  
 Sheehan Disability Scale Difference 
Intercept -4.159 1.320 -3.151 .002 -6.754 -1.564  
Race -2.568 2.139 -1.201 .230 -6.770 1.634 .246 
Baseline Sheehan -.557 .164 -3.399 .001 -.880 -.235  
 Coding Difference 
Intercept 12.210 2.249 5.429 <.001 7.802 16.619  
Race -6.249 3.622 -1.725 .084 -13.349 .850 .806 
Baseline Coding -.470 .112 -4.194 <.001 -.689 -.250  
 Combined Color Naming & Word Reading Difference 
Intercept .648 .365 1.774 .078 -.073 1.369  
Race -1.039 .606 -1.714 .093 -2.258 .180 .568 
Baseline CNR -.491 .119 -4.121 <.001 -.725 -.256  
 Number Sequencing Difference 
Intercept -7.573 1.149 -6.589 .000 -9.841 -5.305  
Race 2.336 1.952 1.197 .235 -1.542 6.214 -.143 
Baseline Number 
Sequencing 
-.544 .095 -5.746 <.001 -.730 -.358  
 Letter Fluency Difference 
Intercept 10.965 2.212 4.957 <.001 6.629 15.301  
Race -7.569 3.666 -2.065 .039 -14.762 -.375 .378 
Baseline Letter Fluency -.538 .161 -3.342 .001 -.853 -.222  
 Number-Letter Sequencing Difference 
Intercept -19.226 1.904 -10.097 <.001 -22.958 -15.494  
Race 7.894 3.247 2.431 .016 1.506 14.282 -.275 
Baseline Number-Letter -.714 .061 -11.742 <.001 -.833 -.594  
 Inhibition Difference 
Intercept -4.530 1.944 -2.330 .020 -8.341 -.718  
Race .075 3.284 .023 .982 -6.370 6.520 .170 
Baseline Inhibition  -.372 .145 -2.569 .010 -.656 -.088  
 Digit Span Forward Difference 
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Intercept -.261 .604 -.432 .666 -1.452 .930  
Race .684 1.094 .626 .533 -1.489 2.858 -.464 
Baseline Digit Span 
Forward 
-.380 .241 -1.576 .117 -.857 .096  
 CVLT Total Learning Difference 
Intercept 6.749 1.640 4.116 <.001 3.529 9.970  
Race -2.564 2.603 -.985 .325 -7.668 2.541 .138 
Baseline Total Learning   -.579 .142 -4.087 <.001 -.857 -.301  
 CVLT Short Delay Free Recall Difference 
Intercept 4.701 2.240 2.099 .036 .311 9.092  
Race -2.856 3.643 -.784 .433 -9.997 4.285 .288 
Baseline Short Delay  -1.325 .707 -1.874 .061 -2.712 .062  
 CVLT Long Delay Free Recall Difference 
Intercept 1.781 .486 3.667 .003 .739 2.822  
Race -.127 .646 -.196 .846 -1.432 1.179 .067 
Baseline Long Delay -.684 .166 -4.120 .001 -1.034 -.333  
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Table 10 
Effect of race on regressed change scores of individual tests, covarying for respective baseline 
score and premorbid intellectual functioning 
     95% CI 




 HDRS Difference 
Intercept  -8.007 1.011 -7.919 <.001 -9.988 -6.025 
Race .289 1.887 .153 .878 -3.412 3.991 
Baseline HDRS -.779 .136 -5.708 <.001 -1.047 -.511 
WTAR -.064 .102 -.628 .530 -.264 .136 
 BDI-II Difference 
Intercept -10.914 2.073 -5.264 <.001 -14.978 -6.850 
Race 1.640 4.086 .401 .688 -6.375 9.655 
Baseline BDI -.705 .157 -4.475 <.001 -1.013 -.396 
WTAR -.001 .201 -.007 .994 -.395 .392 
 Sheehan Disability Scale Difference 
Intercept -4.253 1.427 -2.981 .003 -7.066 -1.440 
Race  -2.424 2.565 -.945 .346 -7.482 2.635 
Baseline Sheehan -.556 .170 -3.267 .001 -.890 -.221 
WTAR  .037 .146 .256 .799 -.250 .324 
 Coding Difference 
Intercept 12.165 2.318 5.248 <.001 7.621 16.709 
Race  -7.165 4.184 -1.713 .087 -15.368 1.038 
Baseline Coding -.431 .114 -3.779 <.001 -.655 -.208 
WTAR  .053 .238 .225 .822 -.413 .520 
 Combined Color Naming & Word Reading Difference 
Intercept .460 .386 1.191 .240 -.319 1.239 
Race -.565 .756 -.748 .466 -2.168 1.038 
Baseline CNR -.506 .110 -4.598 <.001 -.722 -.290 
WTAR  .069 .043 1.616 .125 -.021 .158 
 Number Sequencing Difference 
Intercept -7.644 1.250 -6.114 <.001 -10.122 -5.166 
Race 2.695 2.377 1.134 .261 -2.060 7.449 
Baseline Number 
Sequencing  
-.546 .098 -5.562 <.001 -.739 -.353 
WTAR  .029 .124 .233 .816 -.215 .272 
 Letter Fluency Difference 
Intercept 11.298 2.275 4.967 <.001 6.839 15.758 
Race -9.702 4.102 -2.365 .018 -17.751 -1.654 
Baseline Letter Fluency -.461 .177 -2.603 .009 -.808 -.114 
WTAR  -.220 .257 -.855 .393 -.725 .286 
 Number-Letter Sequencing Difference 
Intercept -20.635 1.826 -11.302 <.001 -24.214 -17.057 
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Race 12.516 3.436 3.643 <.001 5.771 19.261 
Baseline Number-Letter -.630 .064 -9.817 <.001 -.755 -.504 
WTAR  .577 .215 2.684 .007 .155 .998 
 Inhibition Difference 
Intercept -5.038 2.042 -2.467 .014 -9.043 -1.034 
Race 1.595 3.767 .424 .672 -5.806 8.996 
Baseline Inhibition  -.329 .156 -2.116 .035 -.634 -.024 
WTAR  .204 .214 .954 .340 -.215 .624 
 Digit Span Forward Difference 
Intercept -.295 .626 -.472 .638 -1.530 .940 
Race .770 1.125 .684 .495 -1.448 2.987 
Baseline Digit Span 
Forward 
-.453 .279 -1.624 .105 -1.003 .096 
WTAR  .036 .070 .513 .608 -.101 .173 
 CVLT Total Learning Difference 
Intercept 6.804 1.745 3.900 <.001 3.376 10.231 
Race -2.663 3.077 -.865 .387 -8.700 3.374 
Baseline Total Learning -.569 .160 -3.563 <.001 -.883 -.256 
WTAR  -.025 .193 -.128 .898 -.404 .355 
 CVLT Short Delay Free Recall Difference 
Intercept 4.800 2.446 1.963 .050 .006 9.594 
Race -3.212 4.565 -.703 .482 -12.162 5.739 
Baseline Short Delay -1.280 .815 -1.570 .117 -2.881 .320 
WTAR  -.034 .269 -.125 .900 -.561 .494 
 CVLT Long Delay Free Recall Difference 
Intercept 1.674 .574 2.919 .016 .390 2.959 
Race .205 .920 .223 .827 -1.787 2.196 
Baseline Long Delay  -.720 .165 -4.375 <.001 -1.064 -.376 
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Table 11 
Baseline characteristics by concurrent treatment 





 M or % SD or n M or % SD or n t or X2 p 
Age at evaluation 20.26 20.26 23.18 5.91 t = -2.42 .020 
Sex      X2 = 0.47 .494 
Male 25.7% 9 36.4% 4   
Female 74.3% 26 63.6% 7   
Race     X2 = 6.38 .173 
White 37.1% 13 72.7% 8   
Black 5.7% 2 0.0% 0   
Hispanic  11.4% 4 18.2% 2   
Asian 34.3% 12 9.1% 1   
Years of completed education 14.00 1.89 14.64 1.96 t = -0.96 .340 
Frequency playing video games per week     X2 = 1.71 .634 
0 hours 34.3% 12 45.5% 5   
1-2 hours 25.7% 9 18.2% 2   
3-4 hours 8.6% 3 18.2% 2   
5+ hours 31.4% 11 18.2% 2   
Hamilton Depression Rating Scale 16.38 5.13 15.91 6.95 t = 0.24 .809 
BDI-II 22.23 11.47 25.32 12.16 t = -0.77 .446 
Sheehan Disability Scale  14.54 6.21 17.18 7.92 t = -1.15 .256 
WTAR 36.50 7.75 46.09 4.44 t = -3.89 <.001 
WAIS Coding  79.65 13.79 67.18 15.32 t = 2.54 .015 
DKEFS Combined Color Naming & Word 
Reading   
12.09 2.01 11.82 2.32 t = 0.37 .710 
DKEFS Number Sequencing  28.50 9.71 29.82 9.02 t = -0.40 .693 
DKEFS Letter Fluency  37.17 11.08 44.55 7.20 t = -2.10 .045 
DKEFS Number-Letter Sequencing  70.81 26.53 60.73 22.60 t = 1.13 .264 
DKEFS Inhibition  46.99 10.87 46.18 10.92 t = 0.21 .832 
WAIS Digit Span Forward  10.66 1.92 11.73 2.05 t = -1.58 .120 
CVLT Total Learning Trials  55.14 8.92 57.18 7.47 t = -0.69 .264 
CVLT Short Delay Free Recall  11.66 2.75 13.27 2.20 t = -1.77 .083 
CVLT Long Delay Free Recall  12.11 2.32 12.82 2.36 t = -0.87 .387 
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Table 12 
Engagement and minutes trained by concurrent treatment  
  
No concurrent treatment Concurrent treatment  
(n=35) (n=11)  
  M SD M SD t p 
Total Minutes Trained 144 132 392 270 -4.14 <.001 
UES Total 90.93 11.15 92.82 10.79 -0.49 .624 
Focused Attention 3.31 0.68 3.18 0.85 0.46 .645 
Perceived Usability 2.49 0.75 2.73 0.86 -0.8 .427 
Aesthetics 4.22 0.55 4.19 0.5 0.16 .871 
Satisfaction 3.7 0.81 3.54 1.11 0.47 .640 
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Table 13  
Effect of concurrent treatment on regressed change scores of individual tests, covarying for 
respective baseline score 
          95% CI  






  HDRS Difference 
Intercept -7.20 0.73 -9.87 <.001 -8.65 -5.76   
Treatment Status  -0.53 1.43 -0.37 0.71 -3.34 2.29 .03 
Baseline HDRS -0.82 0.11 -7.15 <.001 -1.04 -0.59   
  BDI-II Difference 
Intercept -10.35 1.39 -7.45 <.001 -13.10 -7.60   
Treatment Status 1.05 2.69 0.39 .70 -4.23 6.33 .09 
Baseline BDI-II -0.69 0.10 -6.69 <.001 -0.89 -0.49   
  Sheehan Disability Scale Difference  
Intercept -5.55 1.00 -5.55 <.001 -7.52 -3.59   
Treatment Status 1.26 1.97 0.64 .52 -2.60 5.12 .05 
Baseline Sheehan -0.59 0.13 -4.48 <.001 -0.85 -0.33   
  Coding Difference 
Intercept 9.15 1.73 5.29 <.001 5.76 12.54   
Treatment Status 3.99 3.70 1.08 .28 -3.26 11.23 -.74 
Baseline Coding -0.44 0.11 -4.04 <.001 -0.65 -0.23   
  Combined Color Naming & Word Reading Difference 
Intercept 0.55 0.24 2.26 .03 0.07 1.03   
Treatment Status 0.39 0.45 0.88 .38 -0.48 1.27 -.31 
Baseline CNR -0.54 0.10 -5.16 <.001 -0.75 -0.33   
  Number Sequencing Difference 
Intercept -6.06 0.75 -8.04 <.001 -7.55 -4.58   
Treatment Status -1.22 1.47 -0.83 .41 -4.10 1.66 .29 
Baseline Number 
Sequencing 
-0.54 0.07 -7.92 <.001 -0.67 -0.40   
  Letter Fluency  
Intercept 8.89 1.63 5.47 <.001 5.71 12.08   
Treatment Status -1.81 3.43 -0.53 .60 -8.54 4.91 .50 
Baseline Letter Fluency -0.43 0.14 -3.03 <.001 -0.70 -0.15   
  Number–Letter Sequencing Difference 
Intercept -16.02 2.06 -7.76 <.001 -20.07 -11.97   
Treatment Status 1.16 4.19 0.28 .78 -7.06 9.38 -.44 
Baseline Number-Letter -0.74 0.07 -10.14 <.001 -0.88 -0.60   
  Inhibition Difference 
Intercept -5.93 1.38 -4.29 <.001 -8.64 -3.21   
Treatment Status 4.15 2.76 1.51 .13 -1.26 9.56 -.44 
Baseline Inhibition -0.40 0.11 -3.62 <.001 -0.61 -0.18   
  Digit Span Forward Difference 
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Intercept 0.43 0.42 1.04 .30 -0.39 1.25   
Treatment Status -0.92 0.89 -1.03 .30 -2.68 0.84 .11 
Baseline Digit Span 
Forward 
-0.54 0.19 -2.83 .01 -0.91 -0.16   
  CVLT Total Learning Difference 
Intercept 4.07 1.24 3.29 <.001 1.64 6.49   
Treatment Status 2.81 2.48 1.13 .26 -2.06 7.67 -.04 
Baseline Total Learning -0.54 0.13 -4.28 <.001 -0.78 -0.29   
  CVLT Short Delay Free Recall Difference 
Intercept 1.42 1.49 0.95 .34 -1.50 4.35   
Treatment Status 6.29 3.07 2.05 .04 0.27 12.32 -.06 
Baseline Short Delay   -1.44 0.51 -2.85 .01 -2.43 -0.45   
  CVLT Long Delay Free Recall Difference 
Intercept 1.22 0.33 3.75 <.001 0.58 1.86   
Treatment Status 0.72 0.69 1.05 .30 -0.64 2.08 -.02 
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Table 14 
Effect of concurrent treatment on regressed change scores of individual tests, covarying for 
respective baseline scores and premorbid intellectual functioning 
     95% CI 
  





 HDRS Difference 
Intercept -7.47 0.79 -9.46 <.001 -9.04 -5.91 
Treatment Status 0.41 1.65 0.25 .80 -2.81 3.64 
Baseline HDRS -0.81 0.11 -7.09 <.001 -1.04 -0.59 
WTAR  -0.09 0.09 -1.06 .29 -0.26 0.08 
 BDI-II Difference 
Intercept -10.64 1.44 -7.41 <.001 -13.46 -7.82 
Treatment Status 1.86 3.15 0.59 .56 -4.32 8.03 
Baseline BDI-II -0.69 0.11 -6.61 <.001 -0.90 -0.49 
WTAR -0.07 0.17 -0.43 .67 -0.39 0.25 
 Sheehan Disability Scale (Total) Difference 
Intercept -5.25 1.07 -4.89 <.001 -7.36 -3.14 
Treatment Status 0.07 2.37 0.03 .98 -4.58 4.72 
Baseline Sheehan -0.57 0.13 -4.26 <.001 -0.84 -0.31 
WTAR 0.12 0.13 0.95 .34 -0.13 0.36 
 Coding Difference 
Intercept 9.24 1.87 4.95 <.001 5.58 12.90 
Treatment Status 2.44 4.43 0.55 .58 -6.24 11.12 
Baseline Coding  -0.42 0.11 -3.75 <.001 -0.65 -0.20 
WTAR 0.22 0.22 1.00 .32 -0.21 0.65 
 Combined Color Naming & Word Reading Difference 
Intercept 0.10 0.31 0.32 .75 -0.52 0.72 
Treatment Status 0.01 0.65 0.02 .99 -1.26 1.28 
Baseline CNR  -0.56 0.12 -4.76 <.001 -0.80 -0.33 
WTAR 0.05 0.04 1.33 .18 -0.02 0.12 
 Number Sequencing Difference 
Intercept -6.08 0.85 -7.14 <.001 -7.77 -4.40 
Treatment Status -1.17 1.80 -0.65 .51 -4.70 2.36 
Baseline Number Sequencing -0.54 0.07 -7.73 <.001 -0.67 -0.40 
WTAR 0.00 0.10 -0.03 .97 -0.20 0.19 
 Letter Fluency Difference 
Intercept 9.16 1.71 5.35 <.001 0.01 0.01 
Treatment Status -3.31 3.87 -0.86 .39 0.00 0.00 
Baseline Letter Fluency  -0.47 0.15 -3.08 <.001 0.01 0.01 
WTAR 0.20 0.22 0.92 .36 0.02 0.02 
 Number Letter Sequencing Difference  
Intercept -16.82 2.20 -7.65 <.001 0.05 0.05 





Treatment Status 4.14 4.88 0.85 .40 0.01 0.01 
Baseline Number-Letter -0.78 0.08 -9.68 <.001 0.09 0.10 
WTAR -0.34 0.28 -1.21 .23 0.03 0.03 
  
Intercept 4.66 3.38 -4.02 <.001 0.15 0.16 
Treatment Status -0.41 0.12 1.38 .17 0.11 0.12 
Baseline Inhibition -0.05 0.19 -3.37 <.001 0.06 0.06 
WTAR 4.66 3.38 -0.26 .79 0.10 0.11 
 Digit Span Forward Difference 
Intercept 0.51 0.43 1.19 .24 0.05 0.05 
Treatment Status -1.34 1.00 -1.34 .18 0.09 0.10 
Baseline Digit Span Forward -0.67 0.25 -2.73 .01 0.18 0.20 
WTAR 0.06 0.07 0.89 .38 0.20 0.23 
 CVLT Total Learning Difference 
Intercept 4.21 1.33 3.17 <.001 0.04 0.04 
Treatment Status 2.36 2.96 0.80 .43 0.01 0.01 
Baseline Total Learning  -0.56 0.15 -3.89 <.001 0.12 0.13 
WTAR 0.05 0.17 0.28 .78 0.04 0.04 
 CVLT Short Delay Free Recall Difference 
Intercept 1.14 1.60 0.72 .47 0.06 0.07 
Treatment Status 7.17 3.52 2.04 .04 0.01 0.01 
Baseline Short Delay -1.32 0.53 -2.49 .01 0.05 0.05 
WTAR -0.10 0.20 -0.53 .60 0.01 0.01 
 CVLT Long Delay Free Recall Difference 
Intercept 1.33 0.36 3.73 .00 0.19 0.22 
Treatment Status 0.25 0.80 0.31 .76 0.17 0.19 
Baseline Long Delay -0.74 0.13 -5.59 <.001 0.19 0.22 
WTAR 0.05 0.04 1.27 .21 0.12 0.13 
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Table 15 
Effect of depressive severity on regressed change scores of individual tests, covarying for self-
reported baseline depression  
      95% CI  






  HDRS Difference 
Intercept  -7.33 0.61 -11.92 <.001 -8.54 -6.12   
Baseline BDI-II 0.06 0.07 0.87 .38 -0.08 0.20 .208 
Baseline HDRS -0.91 0.15 -5.95 <.001 -1.21 -0.61   
  Sheehan Disability Scale Total Difference  
Intercept -5.25 0.85 -6.16 <.001 -6.93 -3.57   
Baseline BDI-II 0.18 0.11 1.60 .11 -0.04 0.41 .089 
Baseline Sheehan Total -0.81 0.19 -4.25 <.001 -1.19 -0.44   
  Coding Difference 
Intercept 10.10 1.51 6.72 <.001 7.15 13.05   
Baseline BDI-II 0.02 0.13 0.13 .89 -0.24 0.28 .007 
Baseline Coding  -0.48 0.10 -4.64 <.001 -0.68 -0.28   
  Combined Color Naming & Word Reading Difference 
Intercept 0.64 0.21 3.04 <.001 0.22 1.06   
Baseline BDI-II 0.00 0.02 -0.21 .83 -0.04 0.03 .0005 
Baseline CNR -0.55 0.10 -5.27 <.001 -0.75 -0.34   
  Number Sequencing (Trails 2) Difference 
Intercept -6.35 0.66 -9.70 <.001 -7.64 -5.07   
Baseline BDI-II 0.00 0.06 -0.03 .97 -0.12 0.11 .001 
Baseline Number 
Sequencing  
-0.54 0.07 -7.91 <.001 -0.67 -0.41   
  Letter Fluency Difference 
Intercept 8.46 1.41 6.00 <.001 5.70 11.22   
Baseline BDI-II -0.01 0.13 -0.10 .92 -0.27 0.24 .002 
Baseline Letter Fluency -0.45 0.14 -3.30 <.001 -0.72 -0.18   
  Number – Letter Sequencing (Trails 4) Difference 
Intercept -15.74 1.79 -8.81 <.001 -19.25 -12.24   
Baseline BDI-II 0.07 0.16 0.43 .67 -0.25 0.39 .015 
Baseline Number-Letter  -0.75 0.07 -10.18 <.001 -0.89 -0.61   
  Inhibition (Stroop 3) Difference 
Intercept -4.93 1.18 -4.19 <.001 -7.25 -2.62   
Baseline BDI-II 0.17 0.10 1.65 .10 -0.03 0.36 .042 
Baseline Inhibition -0.41 0.11 -3.72 <.001 -0.62 -0.19   
  Digit Span Forward Difference 
Intercept 0.21 0.35 0.60 .55 -0.48 0.90   
Baseline BDI-II -0.03 0.03 -1.04 .30 -0.09 0.03 .019 
Baseline Digit Span 
Forward 
-0.59 0.18 -3.24 <.001 -0.94 -0.23   
  CVLT Total Learning Difference 
Intercept 4.74 1.08 4.39 <.001 2.62 6.85   
Baseline BDI-II -0.07 0.09 -0.70 .48 -0.25 0.12 .025 
Baseline Total Learning -0.51 0.13 -4.03 <.001 -0.76 -0.26   
  CVLT Short Delay Free Recall Difference 
Intercept 2.93 1.31 2.24 .03 0.37 5.49   
Baseline BDI-II 0.16 0.11 1.45 .15 -0.06 0.39 .055 
Baseline Short Delay -1.12 0.51 -2.21 .03 -2.11 -0.12   
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  CVLT Long Delay Free Recall Difference 
Intercept 1.39 0.28 5.07 <.001 0.86 1.93   
Baseline BDI-II -0.01 0.03 -0.34 .74 -0.06 0.04 .003 
Baseline Long Delay  -0.69 0.12 -5.78 <.001 -0.92 -0.45   
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Figure 1 
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